<SEC-DOCUMENT>0001104659-25-107429.txt : 20251106
<SEC-HEADER>0001104659-25-107429.hdr.sgml : 20251106
<ACCEPTANCE-DATETIME>20251106080617
ACCESSION NUMBER:		0001104659-25-107429
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		14
FILED AS OF DATE:		20251106
DATE AS OF CHANGE:		20251106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CENTRUS ENERGY CORP
		CENTRAL INDEX KEY:			0001065059
		STANDARD INDUSTRIAL CLASSIFICATION:	MINING, QUARRYING OF NONMETALLIC MINERALS (NO FUELS) [1400]
		ORGANIZATION NAME:           	01 Energy & Transportation
		EIN:				522107911
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-291305
		FILM NUMBER:		251456279

	BUSINESS ADDRESS:	
		STREET 1:		6901 ROCKLEDGE DR
		STREET 2:		SUITE 800
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20817
		BUSINESS PHONE:		3015643200

	MAIL ADDRESS:	
		STREET 1:		6901 ROCKLEDGE DR
		STREET 2:		SUITE 800
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20817

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	USEC INC
		DATE OF NAME CHANGE:	19980629
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>tm2530029d2_424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed Pursuant to Rule&nbsp;424(b)(5)<BR>
Registration No.&nbsp;333-291305</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>PROSPECTUS SUPPLEMENT<BR>
(to the Prospectus dated November&nbsp;6, 2025)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to $1,000,000,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="tm2530029d2_424b5img001.jpg" ALT=""><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Centrus Energy Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Class&nbsp;A Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In accordance with the terms
of the Sales Agreement entered into with Barclays Capital Inc., Citigroup Global Markets Inc., UBS Securities LLC, Evercore Group L.L.C.,
B. Riley Securities,&nbsp;Inc., Guggenheim Securities, LLC, MUFG Securities Americas Inc., William Blair&nbsp;&amp; Company, L.L.C.,
Lake Street Capital Markets, LLC and Northland Securities,&nbsp;Inc., as sales agents (each, an &ldquo;Agent&rdquo; and, together, the
&ldquo;Agents&rdquo;), dated November&nbsp;6, 2025, which we refer to as the Sales Agreement, we may offer and sell under this prospectus
supplement shares of our Class&nbsp;A Common Stock, $0.10 par value per share (the &ldquo;Class&nbsp;A Common Stock&rdquo;), having an
aggregate offering price of up to $1,000,000,000, from time to time, through or to the Agents, acting as sales agents or principals.
In connection with the entry into the Sales Agreement, we terminated our &ldquo;at the market offering&rdquo; program pursuant to our
prior sales agreement, dated as of February&nbsp;9, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Class&nbsp;A Common
Stock is traded on the NYSE American LLC (the &ldquo;NYSE&rdquo;) under the symbol &ldquo;LEU.&rdquo; The last reported sale price of
our Class&nbsp;A Common Stock on November&nbsp;5, 2025 was $<FONT STYLE="font-family: Symbol">325.73</FONT> per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The shares of Class&nbsp;A
Common Stock offered under this prospectus supplement, if any, may be sold in ordinary brokers&rsquo; transactions on the NYSE or otherwise,
at market prices prevailing at the time of sale, in block transactions, in negotiated transactions, in any manner permitted by applicable
law or as otherwise agreed with the Agents. Under the terms of the Sales Agreement, we may also sell our Class&nbsp;A Common Stock to
an Agent as principal for its own account at a price agreed upon at the time of sale. If we sell shares of our Class&nbsp;A Common Stock
to any Agent as principal, we will enter into a separate terms agreement with the Agent, setting forth the terms of such transaction,
and we will describe the agreement in a separate prospectus supplement or pricing supplement. The Agents are not required to sell any
specific amount of shares of our Class&nbsp;A Common Stock, but will act as our sales agents using reasonable efforts consistent with
their normal trading and sales practices. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Agents will be entitled
to compensation at a commission rate equal to 1.5% of the gross sales price per share of our Class&nbsp;A Common Stock sold through it
or to them as sales agent under the Sales Agreement. In connection with the sale of our Class&nbsp;A Common Stock on our behalf, an Agent
may be deemed to be an &ldquo;underwriter&rdquo; within the meaning of the Securities Act of 1933, as amended (the &ldquo;Securities
Act&rdquo;) and the compensation of the Agents may be deemed to be underwriting commissions or discounts. We have also agreed to provide
indemnification and contribution to the Agents with respect to certain liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Investing in our Class&nbsp;A
Common Stock involves a high degree of risk. Before buying shares of our Class&nbsp;A Common Stock, you should carefully consider the
risk factors described in &ldquo;Risk Factors&rdquo; beginning on page&nbsp;S-<FONT STYLE="font-family: Symbol">4</FONT> of this prospectus
supplement, the section captioned &ldquo;Item 1A&mdash;Risk Factors&rdquo; in our most recently filed Annual Report on Form&nbsp;10-K
and subsequent Quarterly Reports on Form&nbsp;10-Q, which are incorporated by reference into this prospectus supplement, and under similar
headings in the other documents that are filed after the date hereof and incorporated by reference into this prospectus supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Neither the Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Barclays</B></FONT></TD>
    <TD STYLE="text-align: center; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Citi</B></FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><B>UBS Investment Bank</B></TD>
    <TD STYLE="width: 25%; text-align: center"><B>Evercore ISI</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><B>B. Riley Securities</B> &nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Guggenheim
    Securities</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MUFG</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
    Blair</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lake
    Street</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Northland
    Capital Markets</B></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus supplement is November&nbsp;6,
2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding: 0.25pt 0.25pt 1.25pt 0.5pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt 0.25pt 1.25pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page&nbsp;</B></FONT></TD>
    <TD STYLE="padding: 0.25pt 0.25pt 1.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 87%; padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#ka_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT
    THIS PROSPECTUS SUPPLEMENT</FONT></A></TD>
    <TD STYLE="width: 1%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 10%; padding: 0.25pt; text-align: right"><A HREF="#ka_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-iii</FONT></A></TD>
    <TD STYLE="width: 1%; padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#ka_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPECIAL
    NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#ka_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-iv</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#ka_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS
    SUPPLEMENT SUMMARY</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#ka_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#ka_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
    OFFERING</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#ka_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-3</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#ka_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK
    FACTORS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#ka_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-4</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#ka_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE
    OF PROCEEDS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#ka_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-7</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#ka_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIVIDEND
    POLICY</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#ka_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-8</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#ka_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN
    OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#ka_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-9</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#ka_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL
    MATTERS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#ka_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-11</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#ka_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#ka_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-11</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#ka_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE
    YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#ka_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-11</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#ka_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION
    OF CERTAIN DOCUMENTS BY REFERENCE</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#ka_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-12</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 1.5pt 0.5pt; width: 87%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prospectus</B></FONT></TD>
    <TD STYLE="padding: 0.25pt 0.25pt 1.25pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; text-align: right; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page&nbsp;</B></FONT></TD>
    <TD STYLE="padding: 0.25pt 0.25pt 1.25pt; width: 1%">&nbsp;</TD></TR>

<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_001">About
    This Prospectus</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_001">1</A></FONT></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_002">Where
    You Can Find More Information</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_002">2</A></FONT></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_003">Information
    We Incorporate By Reference</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_003">3</A></FONT></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_004">Special
    Note Regarding Forward-Looking Statements</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_004">4</A></FONT></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_005">Centrus
    Energy Corp.</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_005">8</A></FONT></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_006">Risk
    Factors</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_006">9</A></FONT></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_007">Use
    Of Proceeds</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_007">10</A></FONT></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_008">Description
    Of Capital Stock</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_008">11</A></FONT></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_009">Description
    Of Debt Securities</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_009">13</A></FONT></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_010">Description
    Of Warrants</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_010">19</A></FONT></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_011">Description
    Of Rights</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_011">22</A></FONT></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_012">Description
    Of Units</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_012">23</A></FONT></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_013">Plan
    Of Distribution</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_013">24</A></FONT></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_014">Legal
    Matters</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_014">26</A></FONT></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_015">Experts</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><FONT STYLE="text-transform: uppercase"><A HREF="#a_015">26</A></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="ka_001"></A><B>ABOUT THIS PROSPECTUS
SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This prospectus supplement
and the accompanying prospectus form part of a registration statement on Form&nbsp;S-3 that we filed with the SEC as a &ldquo;well-known
seasoned issuer,&rdquo; as such term is defined in Rule&nbsp;405 of the Securities Act, using a &ldquo;shelf&rdquo; registration process.
This document is in two parts. The first part is this prospectus supplement, which contains specific information about the terms on which
we are offering and selling our Class&nbsp;A Common Stock and important business information about us. The second part is the accompanying
prospectus, which contains and incorporates by reference important business and financial information about us and other information
about this offering. This prospectus supplement and the accompanying prospectus are part of a shelf registration statement that we filed
with the SEC under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In making your investment
decision, you should rely only on the information contained in or incorporated by reference in this prospectus supplement, the accompanying
prospectus and any free writing prospectus filed by us with the SEC. We are responsible for the information contained in this prospectus
supplement and the accompanying prospectus, including the information incorporated by reference herein as described herein and therein,
and any free writing prospectus that we prepare and distribute. Neither we nor the Agents have authorized anyone to provide you with
information different from that contained in or incorporated by reference into this prospectus supplement, the accompanying prospectus
or any such free writing prospectus. Neither we nor the Agents are making an offer to sell, or soliciting an offer to buy, these securities
in any jurisdiction where the offer or sale is not permitted. The information contained or incorporated by reference in this prospectus
supplement, the accompanying prospectus or any related free writing prospectus prepared by us is accurate only as of the date of the
applicable document. Our business, financial condition, results of operations and prospects may have changed since that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This prospectus supplement
and the accompanying prospectus do not contain all of the information included in the registration statement as permitted by the rules&nbsp;and
regulations of the SEC. For further information, we refer you to the registration statement on Form&nbsp;S-3, including its exhibits,
of which this prospectus supplement and the accompanying prospectus form a part. We are subject to the informational requirements of
the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), and therefore file reports and other information with
the SEC. Statements contained in this prospectus supplement and the accompanying prospectus about the provisions or contents of any agreement
or other document are only summaries. If SEC rules&nbsp;require that any agreement or document be filed as an exhibit to the registration
statement, you should refer to that agreement or document for its complete contents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Before you invest in our
Class&nbsp;A Common Stock, you should read the registration statement of which this document forms a part and this document, including
the documents incorporated by reference in this prospectus supplement and the accompanying prospectus that are described under the captions
&ldquo;Where You Can Find More Information&rdquo; and &ldquo;Information We Incorporate by Reference&rdquo; in this prospectus supplement
and the accompanying prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If the description of this
offering and our business varies between this prospectus supplement and the accompanying prospectus, you should rely on the information
in this prospectus supplement. Any statement made in this prospectus supplement or in a document incorporated or deemed to be incorporated
by reference in this prospectus supplement may be deemed to be modified or superseded for purposes of this prospectus supplement to the
extent that a statement contained in this prospectus supplement or in any other subsequently filed document that is also incorporated
or deemed to be incorporated by reference in this prospectus supplement modifies or supersedes that statement. Any statement so modified
or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Unless otherwise expressly
indicated or the context otherwise requires, we use the terms &ldquo;Centrus,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo;
&ldquo;our&rdquo; or similar references to refer to Centrus Energy Corp., a Delaware corporation, and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ka_002"></A>SPECIAL NOTE REGARDING
FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This prospectus supplement,
including the documents incorporated by reference herein, may contain or incorporate &ldquo;forward-looking statements&rdquo; within
the meaning of Section&nbsp;21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act
of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business
and financial performance, and often contain words such as &ldquo;expects&rdquo;, &ldquo;anticipates&rdquo;, &ldquo;intends&rdquo;, &ldquo;plans&rdquo;,
&ldquo;believes&rdquo;, &ldquo;will&rdquo;, &ldquo;should&rdquo;, &ldquo;could&rdquo;, &ldquo;would&rdquo; or &ldquo;may&rdquo; and other
words of similar meaning. These forward-looking statements are based on information available to us as of the date of this prospectus
supplement and represent management&rsquo;s current views and assumptions with respect to future events and operational, economic and
financial performance. Forward-looking statements are not guarantees of future performance, events or results and involve known and unknown
risks, uncertainties and other factors, which may be beyond our control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For Centrus, particular
risks and uncertainties (hereinafter &ldquo;risks&rdquo;) that could cause our actual future results to differ materially from those
expressed in our forward-looking statements include but are not limited to the following and which are, and may be, exacerbated by any
worsening of the global business and economic environment include but are not limited to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Risks related to the
war in Ukraine factors</B>&nbsp;primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to the geopolitical conflicts and the imposition of sanctions or other measures,
                                            including bans or tariffs, by (i)&nbsp;the U.S. or foreign governments and institutions such
                                            as the European Union, (ii)&nbsp;organizations (including the United Nations or other international
                                            organizations), and/or (iii)&nbsp;entities (including private entities or persons), that
                                            could directly or indirectly impact our financial position or ability to obtain, deliver,
                                            transport, or sell low-enriched uranium (&ldquo;LEU&rdquo;) or the separate work units (&ldquo;SWU&rdquo;)
                                            and natural uranium hexafluoride components of LEU delivered to us under the TENEX Supply
                                            Contract or other supply contracts or make related payments or deliveries of natural uranium
                                            hexafluoride to TENEX, Joint Stock Company (&ldquo;TENEX&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to laws or other government measures that ban, delay or restrict (i)&nbsp;imports
                                            of Russian LEU into the United States, including but not limited to the Prohibiting Russian
                                            Uranium Imports Act (the &ldquo;Import Ban Act&rdquo;), or (ii)&nbsp;transactions with Rosatom
                                            or its subsidiaries, which include TENEX, or (iii)&nbsp;exports of Russian LEU from Russia
                                            to the United States or any entity that is a U.S. entity or that transacts with a U.S. entity,
                                            including but not limited to Russian Federal Decree No.&nbsp;1544 (the &ldquo;Russian Decree&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to our potential inability to secure additional U.S. government waivers from the
                                            Import Ban Act in a timely manner or at all in order to allow us to continue importing Russian
                                            LEU under the TENEX Supply Contract or implementing the TENEX Supply Contract;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to TENEX&rsquo;s refusal or its prohibition or inability to deliver, or timely deliver,
                                            LEU to us for any reason, including (i)&nbsp;U.S. or foreign government sanctions, bans,
                                            or decrees imposed on LEU from Russia or on TENEX, (ii)&nbsp;TENEX being unable, prohibited
                                            or unwilling to receive payments, receive the return of natural uranium hexafluoride, or
                                            conduct other activities related to the TENEX Supply Contract, (iii)&nbsp;TENEX elects, or
                                            is directed (including by its owner or the Russian government), to limit, pause or stop transactions
                                            with us or with the United States or other countries or (iv)&nbsp;TENEX is unable to secure
                                            specific export licenses from the Russian authorities as required by the Russian Decree for
                                            each shipment or secure them in a timely manner to ship Russian LEU to the United States,
                                            or such export licenses, once secured, are subsequently rescinded prior to shipment;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to laws, sanctions or other government measures that prohibit or restrict doing business
                                            with TENEX; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to disputes with third parties, including contractual counterparties, that could
                                            result if we do not receive timely deliveries of LEU under the TENEX Supply Contract and
                                            are unable to rely on contractual protections.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>Risks related to economic and industry factors</B>&nbsp;primarily
include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to our dependence on others, such as TENEX, under the TENEX Supply Contract, Orano,
                                            under the Orano Supply Agreement, and other suppliers (including, but not limited to, transporters,
                                            fabricators or converters) who provide, or deliver, to us the goods and services we need
                                            to conduct our business and any resulting negative impact on our liquidity;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to our ability to sell, transport or deliver the LEU we procure pursuant to our purchase
                                            obligations under our supply agreements and the impacts of sanctions or limitations on imports
                                            of such LEU, including those imposed under the 1992 Russian Suspension Agreement, international
                                            trade legislation and other international trade restrictions including but not limited to
                                            the Import Ban Act and Russian Decree;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to the increasing quantities of LEU being imported into the United States from China
                                            and the impact on our ability to make future LEU or SWU sales or ability to finance any build-out
                                            of our enrichment capacities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to change in laws, tariffs or other government measures that would lift, lower or
                                            relax such laws, tariffs or government measures to allow the importation of LEU, or increase
                                            its cost, from Russia or other countries with restrictions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to not being able to sell the Russian LEU available for purchase under the TENEX
                                            Supply Contract for import in 2026 or 2027 for any reason, including customers having filled
                                            their fuel needs for those years;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to whether or when government funding or demand for high assay low-enriched uranium
                                            (&ldquo;HALEU&rdquo;) for government or commercial uses will materialize and at what level;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            regarding funding for continuation and deployment of the American Centrifuge technology;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to (i)&nbsp;our ability to perform and absorb costs under the HALEU Operation Contract,
                                            (ii)&nbsp;our ability to obtain new contracts and funding to be able to continue operations
                                            and (iii)&nbsp;our ability to obtain and/or perform under other agreements;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            that (i)&nbsp;we may not obtain the full benefit of the HALEU Operation Contract and may
                                            not be able or allowed to operate the HALEU enrichment facility to produce HALEU after the
                                            completion of the HALEU Operation Contract or (ii)&nbsp;the output from the HALEU enrichment
                                            facility may not be available to us as a future source of supply;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to existing or new trade barriers, and related to contract terms, that limit our
                                            ability to procure LEU for, or sell, transport or deliver LEU to, customers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to pricing trends and demand in the uranium and enrichment markets and their impact
                                            on our profitability;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to the movement and timing of customer orders;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to the fact that we face significant competition from major LEU producers who may
                                            be less cost sensitive or are wholly or partially government owned;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            that our ability to compete in foreign markets may be limited for various reasons, including
                                            policies that favor indigenous suppliers over foreign suppliers of goods and services;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to the fact that our revenue is largely dependent on our largest customers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to our backlog, including uncertainty concerning customer actions under current contracts
                                            and in future contracting attributable to market conditions, global events or other factors,
                                            including our lack of current production capability;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to natural and other disasters, including the continued impact of the March&nbsp;2011
                                            earthquake and tsunami in Japan, on the nuclear industry and on our business, results of
                                            operations and prospects;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to financial difficulties experienced by customers or suppliers, including possible
                                            bankruptcies, insolvencies, or any other situation, event or occurrence that affect the ability
                                            of others to pay for our products or services in a timely manner or at all;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to pandemics, endemics, and other health crises; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to the impact and potential extended duration of a supply/demand imbalance in the
                                            market for LEU.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Risks related to operational
factors</B>&nbsp;primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the U.S. Department of Energy (&ldquo;DOE&rdquo;) not issuing any major task orders
                                            to any contract awardee under any of the HALEU Production Contract, LEU Production Contract,
                                            or HALEU Deconversion Contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the Company not winning additional task orders under the HALEU Production Contract,
                                            LEU Production Contract and HALEU Deconversion Contract to expand the capacity of the American
                                            Centrifuge plant;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to DOE not providing an adequate share of the appropriated funding to the Company
                                            under any of the HALEU Production Contract, LEU Production Contract, or HALEU Deconversion
                                            Contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our ability to secure financing to expand our plant for LEU or HALEU or expand
                                            it to the level that would make it commercially viable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the DOE not exercising additional options under Phase 3 of the HALEU Operation
                                            Contract or awarding a third party to continue the HALEU Operation Contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our inability to increase capacity for HALEU or LEU in a timely manner to meet
                                            market demand or our contractual obligations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to DOE not awarding any contracts to the Company in response to the Company&rsquo;s
                                            future proposals;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to reliance on the only firm that has the necessary permits and capability to transport
                                            LEU from Russia to the United States and that firm&rsquo;s ability to maintain those permits
                                            and capabilities or secure additional permits;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the ongoing government shutdown or lack of funding that could result in program
                                            cancellations, disruptions and/or stop work orders and could limit the U.S. government&rsquo;s
                                            ability to make timely payments, including under Executive Order 14158, and our ability to
                                            perform under our U.S. government contracts and successfully compete for work including under
                                            the HALEU Operation Contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to changes to the U.S. government&rsquo;s appropriated funding levels for HALEU Operation
                                            Contract due to changes in U.S. government policy or other reasons;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to uncertainty regarding our ability to commercially deploy competitive enrichment
                                            technology;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the potential for demobilization or termination of the HALEU Operation Contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            that we will not be able to timely complete the work that we are obligated to perform;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the government&rsquo;s inability to satisfy its obligations, including supplying
                                            government furnished equipment necessary for us to produce and deliver HALEU under the HALEU
                                            Operation Contract and processing security clearance applications resulting from a government
                                            shutdown or other reasons;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our inability to obtain the government&rsquo;s approval to extend the term of,
                                            or the scope of permitted activities under, our lease with the DOE in Piketon, Ohio;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to security, including cybersecurity, incidents that may impact our business operations,
                                            including incidents that may relate to the ongoing conflict in the Middle East and other
                                            regions of concern;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our inability to perform under fixed-price and cost-share contracts such as the
                                            HALEU Operation Contract, including the risk that costs that we must incur could be higher
                                            than expected and the risk related to complying with stringent government contractual requirements;
                                            and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our inability to attract qualified employees necessary for the planned expansion
                                            of our operations in Oak Ridge, Tennessee or Piketon, Ohio.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>Risks related to financial factors</B>&nbsp;primarily
include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our long-term liabilities, including our defined benefit pension plan obligations
                                            and postretirement health and life benefit obligations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our 0% and 2.25% Convertible Notes maturing in 2032 and 2030, respectively;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            of revenue and operating results fluctuating significantly from quarter to quarter, and in
                                            some cases, year to year;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the impact of financial market conditions on our business, liquidity, prospects,
                                            pension assets and insurance facilities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the Company&rsquo;s capital concentration;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the value of our intangible assets related to LEU segment&rsquo;s backlog and
                                            customer relationships;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to decisions made by our Class&nbsp;B Common Stock stockholders regarding their investment
                                            in the Company, including decisions based upon factors that are unrelated to the Company&rsquo;s
                                            performance;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            that a small number of holders of our Class&nbsp;A Common Stock (whose interests may not
                                            be aligned with other holders of our Class&nbsp;A Common Stock) may exert significant influence
                                            over the direction of the Company and may be motivated by interests that are not aligned
                                            with the Company&rsquo;s other Class&nbsp;A stockholders;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to (i)&nbsp;the use of our net operating loss (&ldquo;NOL&rdquo;) carryforwards and
                                            net unrealized built in losses (&ldquo;NUBILs&rdquo;) to offset future taxable income and
                                            the use of the Rights Agreement to prevent an &ldquo;ownership change&rdquo; as defined in
                                            Section&nbsp;382 of the Internal Revenue Code and (ii)&nbsp;our ability to generate taxable
                                            income to utilize all or a portion of the NOLs prior to the expiration thereof and NUBILs;
                                            and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to failures or security, including cybersecurity, breaches of our information technology
                                            systems.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>Risks related to general factors</B>&nbsp;primarily
include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our ability to attract and retain key personnel;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            that we will be unable to obtain new business opportunities or achieve market acceptance
                                            of our products and services or that products or services provided by others will render
                                            our products or services obsolete or noncompetitive;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to actions, including investigations, reviews or audits, that may be taken by the
                                            U.S. government, the Russian government, or other governments that could affect our ability
                                            to perform under our contractual obligations or the ability of our sources of supply to perform
                                            under their contractual obligations to us;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our inability to perform and receive timely payment under our agreements with
                                            the DOE or other government agencies, including risks related to the ongoing funding by the
                                            government and potential audits;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to how aligned we may be, or perceived to be, with any political party, administration,
                                            or its policies based on our positions or our political action committee&rsquo;s advocacy;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vii<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to changes or termination of our agreements with the U.S. government or other counterparties,
                                            or the exercise of contract remedies by such counterparties, or U.S. government rights in
                                            our intellectual property based on such agreements;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the competitive environment for our products and services;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to changes in the nuclear energy industry;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the competitive bidding process associated with obtaining contracts, including
                                            government contracts; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to potential strategic transactions that could be difficult to implement, that could
                                            disrupt our business or that could change our business profile significantly.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>Risks related to legal and compliance factors</B>&nbsp;primarily
include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the outcome of legal proceedings and other contingencies (including lawsuits and
                                            government investigations or audits);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the impact of, or changes to, government regulation and policies or interpretation
                                            of laws or regulations, including by the DOE, the U.S. Department of Commerce and the </FONT>U.S.
                                            Nuclear Regulatory Commission <FONT STYLE="background-color: white">(&ldquo;NRC&rdquo;);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the recent U.S. federal government administration&rsquo;s reliance on executive
                                            orders to implement regulatory or trade policy and objectives, which could exacerbate regulatory
                                            or, private or public, financing unpredictability;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            of accidents during the transportation, handling, or processing of toxic hazardous or radioactive
                                            material that may pose a health risk to humans or animals, cause property or environmental
                                            damage, or result in precautionary evacuations, and lead to claims against the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            associated with claims and litigation arising from past activities at sites we currently
                                            operate or past activities at sites that we no longer operate, including the Paducah GDP
                                            and Portsmouth GDP; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">other
                                            risks discussed in this and our other filings with the SEC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">These factors may not constitute
all factors that could cause actual results to differ from those discussed in any forward-looking statement. All written and oral forward-looking
statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the cautionary statements
disclosed under &ldquo;Item 1A. Risk Factors,&rdquo; in our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2024
and our Quarterly Report on Form&nbsp;10-Q for the quarterly period ended September&nbsp;30, 2025 and under the sections entitled &ldquo;Risk
Factors&rdquo; in this prospectus supplement and the accompanying prospectus filed with the SEC on November&nbsp;6, 2025, as such risk
factors may be amended, supplemented or superseded from time to time by other reports we file with the SEC, including subsequent Annual
Reports on Form&nbsp;10-K and Quarterly Reports on Form&nbsp;10-Q, and in any subsequent prospectus supplement. Accordingly, forward-looking
statements should not be relied upon as a predictor of actual results. Readers are urged to carefully review and consider the various
disclosures made in this report and in our other filings with the SEC that attempt to advise interested parties of the risks and factors
that may affect our business. We do not undertake to update our forward-looking statements to reflect events or circumstances that may
arise after the date of this prospectus supplement, except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->viii<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<DIV STYLE="border: Black 1pt solid; padding: 10pt 7pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="ka_003"></A><B>PROSPECTUS SUPPLEMENT
SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><I>This summary highlights
the information contained elsewhere in this prospectus supplement, the accompanying prospectus and the documents incorporated by reference
herein and therein and is qualified in its entirety by reference to the more detailed information and financial statements appearing
elsewhere in this prospectus supplement. Because this is only a summary, it does not contain all of the information that may be important
to you. Before investing in our Class A Common Stock, you should read this entire prospectus supplement, the accompanying prospectus
and any related free writing prospectus, together with all documents incorporated by reference herein and therein, carefully, including
the &ldquo;Risk Factors&rdquo; section of this prospectus supplement, in our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000006/leu-20241231.htm" STYLE="-sec-extract: exhibit">Annual
Report on Form 10-K for the year ended December 31, 2024</A> and our <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000162828025049844/leu-20250930.htm">Quarterly Report on Form 10-Q for the quarter ended September 30, 2025</A>, as such risk factors may be amended, supplemented or superseded from time to time by other reports we file with the SEC, including
subsequent Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, and in any subsequent prospectus supplement, and our consolidated
financial statements and related notes incorporated by reference in this prospectus supplement, before making an investment decision.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Company </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt">Centrus is a trusted supplier
of nuclear fuel components for the nuclear power industry, which provides a reliable source of carbon free energy and provides enrichment
and technical services for public and private customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt">Centrus operates two business
segments: (a) LEU, which supplies various components of nuclear fuel to commercial customers from our global network of suppliers, and
(b) Technical Solutions, which provides advanced uranium enrichment for the nuclear industry and the U.S. government and advanced manufacturing
and other technical services to government and private sector customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt">Our LEU segment provides most
of the Company&rsquo;s revenue and involves the sale of enriched uranium, the fissile component of nuclear fuel, primarily to utilities
that operate commercial nuclear power plants. The majority of these sales are for the enrichment component of LEU, which is measured
in SWU. Centrus also sells natural uranium hexafluoride (the raw material needed to produce LEU) and occasionally sells uranium concentrates,
uranium conversion, or LEU with the natural uranium hexafluoride and SWU components combined into one sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt">LEU is a critical component
in the production of nuclear fuel for reactors that produce electricity. We supply LEU and its components to both domestic and international
utilities for use in nuclear reactors worldwide. We provide LEU from multiple sources, including medium- and long-term supply contracts,
spot purchases and our inventory. As a long-term supplier of LEU to our customers, our objective is to provide value through the reliability
and diversity of our supply sources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt">Published spot price indicators
for SWU reached previous historic highs in April 2009 at $163 per SWU. In the years following the 2011 Fukushima accident in Japan, spot
prices declined more than 75%, bottoming out in August 2018 at $34 per SWU. This was followed by a period of price increases, which reached
$195 per SWU by December 31, 2024, which surpassed the previous historic high. As of September 30, 2025, spot prices were $220 per SWU.
This represents an increase of 13% since the beginning of the year and an increase of 547% over the 2018 historic low. This surge in
the SWU spot price beginning in 2022 has been driven primarily by uncertainty created as a result of the war in Ukraine, coupled with
growing interest in nuclear power as a source of reliable carbon-free energy. The contemplation of the imposition of tariffs on LEU,
if ultimately imposed, may put additional upward pressure on the price of SWU.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt">When Russian supply is included,
the uranium enrichment segment of the global nuclear fuel market is oversupplied. But without Russian supply, the global market for uranium
enrichment would be undersupplied. Further, it is not clear that there are sufficient inventories of enriched uranium in the United States
to compensate for a loss of Russian supply, absent new capacity that will take a number of years to deploy.</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<DIV STYLE="border: Black 1pt solid; padding: 10pt 7pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt">Changes in the supply-demand
balance and in the competitive landscape arising from the war in Ukraine or the imposition of tariffs, may affect pricing trends, change
customer spending patterns, and create additional uncertainty in the uranium market. At the same time, uncertainty remains about future
demand for nuclear power generation. To address such changes and uncertainty, we continue to evaluate opportunities to grow our business
organically or through acquisitions and other strategic transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt">Our Technical Solutions segment
is committed to the restoration of America&rsquo;s domestic uranium enrichment production capability in order to play a critical role
in meeting U.S. national security and energy security requirements and advancing America&rsquo;s nonproliferation, energy, and climate
objectives. Our Technical Solutions segment is also focused on repairing broken and vulnerable supply chains, providing clean energy
jobs, and supporting the communities in which we operate. Our goal is to deliver major components of the next-generation nuclear fuels
that will provide reliable carbon-free power around the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22pt">We are also actively considering
and expect to consider potential strategic transactions from time to time, which could involve, without limitation, acquisitions and/or
dispositions of businesses or assets, joint ventures or investments in businesses, products or technologies or changes to our capital
structure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20.15pt">Our principal executive office is located at
6901 Rockledge Drive, Suite 800, Bethesda, Maryland 20817, and our telephone number is (301) 564-3200. Our website is www.centrusenergy.com.
The information located on, or accessible from, our website is not, and should not be deemed to be, part of this prospectus supplement
or incorporated into any other filing that we submit to the SEC.</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border: Black 1pt solid; padding-top: 10pt; text-align: center; padding-bottom: 10pt"><B><A NAME="ka_004"></A>THE OFFERING</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class&nbsp;A
    Common Stock offered by us pursuant to this prospectus supplement</FONT></TD>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of our
    Class&nbsp;A Common Stock having an aggregate offering price of up to $1,000,000,000. </FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class&nbsp;A
    Common Stock to be outstanding after this offering</FONT></TD>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up to 20,562,859
shares, assuming sales at a price of $325.73 per share, which was the closing price on the NYSE on November&nbsp;5, 2025. The actual
number of shares issued will vary depending on the sales price under any offering from time to time.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manner of offering</FONT></TD>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;At the
    market offering&rdquo; that may be made from time to time through or to an Agent, as sales agent or principal. See the section entitled
    &ldquo;Plan of Distribution&rdquo; below.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of proceeds</FONT></TD>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We intend to
    use the net proceeds for general working capital and corporate purposes, which may include investment in technology development and
    deployment, repayment or repurchase of outstanding debt, capital expenditures, potential acquisitions and other business opportunities
    and purposes. See the section entitled &ldquo;Use of Proceeds&rdquo; below.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk factors</FONT></TD>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See &ldquo;Risk
    Factors&rdquo; beginning on page&nbsp;S-</FONT><FONT STYLE="font-family: Symbol; font-size: 10pt">4</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
    the other information included in, or incorporated by reference into, this prospectus supplement for a discussion of certain factors
    you should carefully consider before deciding to invest in shares of our Class&nbsp;A Common Stock.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NYSE symbol</FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEU</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -3in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ka_005"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Investing in our Class&nbsp;A
Common Stock involves a high degree of risk. You should carefully consider the following risk factors, as well as other information in
this prospectus supplement, the accompanying prospectus and the documents incorporated by reference in this prospectus supplement, including
the factors discussed under the heading &ldquo;Risk Factors&rdquo; in our most recent Annual Report on Form&nbsp;10-K and each subsequently
filed Quarterly Report on Form&nbsp;10-Q and any risk factors set forth in our other filings with the SEC pursuant to Sections 13(a),
13(c), 14 or 15(d)&nbsp;of the Exchange Act, before deciding whether to invest in shares of our Class&nbsp;A Common Stock. See &ldquo;Where
You Can Find More Information&rdquo; and &ldquo;Information We Incorporate By Reference.&rdquo; The occurrence of any of the events described
below could harm our business, financial condition, results of operations and growth prospects. In such an event, the trading price of
our Class&nbsp;A Common Stock may decline, and you may lose all or part of your investment.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Additional Risks Related to This Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We will have broad discretion in the use
of the net proceeds from this offering and, despite our efforts, we may use the net proceeds in a manner that does not increase the value
of your investment.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We intend to use the net
proceeds from the sale of shares of our Class&nbsp;A Common Stock in this offering for general working capital and corporate purposes,
which may include investment in technology development and deployment, repayment or repurchase of outstanding debt, capital expenditures,
potential acquisitions and other business opportunities and purposes. We retain broad discretion over the use of the net proceeds from
the sale of shares of Class&nbsp;A Common Stock and, accordingly, you will need to rely upon the judgment of our board of directors and
management with respect to the use of proceeds, potentially with only limited information concerning our specific intentions. These proceeds
could be applied in ways that do not improve our operating results or increase the value of your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If you purchase the Class&nbsp;A Common
Stock sold in this offering, you may experience immediate and substantial dilution in your investment.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Because the price per share
of our Class&nbsp;A Common Stock being offered may be higher than the current book value per share of our Class&nbsp;A Common Stock,
you may experience immediate and substantial dilution with respect to the net tangible book value of the shares of Class&nbsp;A Common
Stock you purchase in this offering. The actual amount of dilution will be based on a number of factors, including the use of proceeds,
and cannot be determined at this time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The actual number of shares we may issue
under the Sales Agreement, at any one time or in total, is uncertain and you may experience future dilution as a result of future equity
offerings.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Subject to certain limitations
in the Sales Agreement and compliance with applicable law, we have the discretion to deliver a sales notice to an Agent at any time throughout
the term of the Sales Agreement. The number of shares that are sold by the Agents after delivering a sales notice, if any, will fluctuate
based on the market price of the Class&nbsp;A Common Stock during the sales period and limits we set with the Agents. Because the price
per share of each share sold will fluctuate based on the market price of our Class&nbsp;A Common Stock during the sales period, it is
not possible at this stage to predict the number of shares that will be ultimately issued. In addition, in order to raise additional
capital, we may offer in the future additional shares of our Class&nbsp;A Common Stock or other securities convertible into or exchangeable
for our Class&nbsp;A Common Stock at prices that may not be the same as the price per share in this offering. We may sell shares or other
securities in any other offering at a price per share that is less than the price per share paid by investors in this offering, and investors
purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at which
we sell additional shares of our Class&nbsp;A Common Stock, or securities convertible or exchangeable into Class&nbsp;A Common Stock,
in future transactions may be higher or lower than the price per share paid by investors in this offering<B><I>.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our governing documents and Delaware law could prevent a takeover
that stockholders consider favorable and could also reduce the market price of our stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our certificate of incorporation,
bylaws and the Section&nbsp;382 Rights Agreement we have adopted with respect to our Class&nbsp;A Common Stock contain certain provisions
that could delay or prevent a change in control. These provisions could also make it more difficult for stockholders to elect directors
and take other corporate actions. These provisions include, without limitation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">a
                                            requirement that stockholders must provide advance notice to propose nominations or have
                                            other business considered at a meeting of stockholders;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">supermajority
                                            stockholder approval to amend our bylaws or certain provisions in our certificate of incorporation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">limitations
                                            on transferability; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">authorization
                                            of blank check preferred stock.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, we are subject
to the provisions of Section&nbsp;203 of the Delaware General Corporation Law. These provisions may prohibit large stockholders, in particular
those owning 15% or more of our outstanding Class&nbsp;A Common Stock, from engaging in certain business combinations without the approval
of substantially all of our stockholders for a certain period of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">These and other provisions
in our certificate of incorporation, bylaws and under Delaware law, including restrictions on foreign ownership and restrictions set
forth in the Section&nbsp;382 Rights Agreement, could discourage potential takeover attempts, reduce the price that investors might be
willing to pay for shares of our Class&nbsp;A Common Stock in the future and result in the market price being lower than it would be
without these provisions. For more information, see &ldquo;Description of Capital Stock&mdash;Provisions of the Company&rsquo;s Certificate
of Incorporation, Bylaws and Delaware Law that May&nbsp;Have an Anti-Takeover Effect&rdquo; in the accompanying prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Volatility in the market price and trading
volume of our Class&nbsp;A Common Stock could negatively affect our stockholders and us.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The stock market in recent
years has experienced significant price and volume fluctuations that have often been unrelated to the operating performance of companies.
The trading price of our Class&nbsp;A Common Stock has been, and is expected to continue to be, volatile. On November 5, 2025, the reported
closing price of Class&nbsp;A Common Stock was $325.73  per share, while on June&nbsp;30, 2025, the reported closing price of our Class&nbsp;A
Common Stock was $183.18 per share and on December&nbsp;31, 2024, the reported closing price of our Class&nbsp;A Common Stock was $66.61
per share. The market price of our Class&nbsp;A Common Stock may fluctuate from time to time as a result of many factors, including but
not limited to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Investors&rsquo;
                                            perceptions of our prospects and the prospects of the LEU and energy markets;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Investors&rsquo;
                                            perceptions of us and/or the industry&rsquo;s risk and return characteristics relative to
                                            other investment alternatives;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
                                            difference between our actual financial and operating results, our earnings and capital guidance
                                            and those expected by investors and analysts;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Changes
                                            in analyst reports, recommendations, or earnings estimates regarding us, other comparable
                                            companies, or the industry generally, and our ability to meet those estimates;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Actual
                                            or anticipated fluctuations in quarterly financial and operating results;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Volatility
                                            in the equity securities market;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sales,
                                            or anticipated sales, of large blocks of our Class&nbsp;A Common Stock; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Impacts
                                            from regulatory changes, including changes resulting from environmental, climate change,
                                            nuclear legislation and regulatory initiatives.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We cannot predict the effect
that issuances or sales of our Class&nbsp;A Common Stock, including pursuant to this offering, may have on the market price for our Class&nbsp;A
Common Stock. The issuance and sale of substantial amounts of our Class&nbsp;A Common Stock, including issuances and sales pursuant to
this offering, could adversely affect the market price of our Class&nbsp;A Common Stock. Many factors could have an impact on the market
price of our Class&nbsp;A Common Stock, including the factors described above and otherwise included or incorporated by reference in
this prospectus supplement and the accompanying prospectus, including those disclosed under the sections captioned &ldquo;Risk Factors&rdquo;
in our reports filed with the SEC referred to above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We plan to sell shares of our Class&nbsp;A
Common Stock in &ldquo;at-the-market offerings&rdquo; and investors who buy shares of our Class&nbsp;A Common Stock at different times
will likely pay different prices.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Investors who purchase shares
of our Class&nbsp;A Common Stock in this offering at different times will likely pay different prices and may experience different outcomes
in their investment results. We will have discretion, subject to the effect of market conditions, to vary the timing, prices, and number
of shares sold in this offering. Investors may experience a decline in the value of their shares of our Class&nbsp;A Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ka_006"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The amount of proceeds from
this offering will depend upon the number of shares of our Class&nbsp;A Common Stock sold and the market price at which they are sold.
There can be no assurance that we will be able to sell any shares under or fully utilize the Sales Agreement with the Agents as a source
of financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We intend to use the net
proceeds for general working capital and corporate purposes, which may include investment in technology development or deployment, repayment
or repurchase of outstanding debt, capital expenditures, potential acquisitions and other business opportunities and purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The precise amount, use
and timing of the application of such proceeds will depend upon our funding requirements and the availability and cost of other capital.
Pending application of the net proceeds as described above, we intend to invest the net proceeds of the offering in short-term, investment-grade,
interest-bearing securities and/or savings accounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ka_007"></A>DIVIDEND POLICY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Centrus has never declared
or paid any cash dividends on its Class&nbsp;A Common stock. We currently anticipate that we will retain all of our future earnings for
use in the expansion and operation of our business and do not anticipate paying any cash dividends in the foreseeable future. Any future
determination to declare cash dividends will be made at the discretion of our board of directors, subject to applicable law and will
depend on our financial condition, results of operations, capital requirements, general business conditions and other factors that our
board of directors may deem relevant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ka_008"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Barclays Capital Inc., Citigroup
Global Markets Inc., UBS Securities LLC, Evercore Group L.L.C., B. Riley Securities,&nbsp;Inc., Guggenheim Securities, LLC, MUFG Securities
Americas Inc., William Blair&nbsp;&amp; Company, L.L.C., Lake Street Capital Markets, LLC and Northland Securities,&nbsp;Inc. (collectively,
the &ldquo;Agents&rdquo;) are acting as the sale agents for this offering. We have entered into the Sales Agreement with the Agents,
the form of which has been or will be filed as an exhibit to a current report on Form&nbsp;8-K incorporated by reference in this prospectus
supplement and the accompanying prospectus. On the terms and subject to the conditions of the Sales Agreement, we may offer and sell
shares of our Class&nbsp;A Common Stock having an aggregate offering price of up to $1,000,000,000 from time to time through the Agents,
as our sales agents or principals. The shares of Class&nbsp;A Common Stock offered hereby will be sold in ordinary brokers&rsquo; transactions
on the NYSE or otherwise, at market prices prevailing at the time of sale, in block transactions, in negotiated transactions, in any
manner permitted by applicable law or as otherwise agreed with the Agents. Under the terms of the Sales Agreement, we may also sell our
Class&nbsp;A Common Stock to an Agent as principal for its own account at a price agreed upon at the time of sale. If we sell shares
of our Class&nbsp;A Common Stock to any Agent as principal, we will enter into a separate terms agreement with the Agent, setting forth
the terms of such transaction, and we will describe the agreement in a separate prospectus supplement or pricing supplement. As sales
agents, the Agents will not engage in any transactions that stabilize the market price of our Class&nbsp;A Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On the terms and subject
to the conditions set forth in the Sales Agreement, the Agents have agreed to use their reasonable efforts to sell shares of our Class&nbsp;A
Common Stock as sales agents. Shares may be offered and sold on a daily basis or as otherwise agreed upon by the Agents and us. We will
designate the minimum offering price or maximum offering price or number of shares of Class&nbsp;A Common Stock, as the case may be,
to be offered through the Agents on a daily basis or otherwise as we and the Agents agree. We may instruct the Agents not to sell shares
of Class&nbsp;A Common Stock if the sales cannot be effected at or above the price designated by us in any such instruction. We or the
Agents may suspend or terminate the offering of shares of Class&nbsp;A Common Stock by notifying the other. We cannot predict the number
of shares of Class&nbsp;A Common Stock that we may sell hereby or if any shares will be sold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Settlement for sales of
Class&nbsp;A Common Stock will occur on the first business day that is also a trading day following the trade date on which such sales
are made, unless another settlement date is agreed upon, in return for payment by investors of the purchase price for the shares being
sold. There is no arrangement for the purchase price paid by investors to be received in an escrow, trust or similar arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We will report at least
quarterly the number of shares of Class&nbsp;A Common Stock sold through the Agents under the Sales Agreement, the net proceeds to us
and the compensation paid by us to the Agents in connection with the sales of Class&nbsp;A Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If we or the Agents have
reason to believe that the exemptive provisions set forth in Rule&nbsp;101(c)(l)&nbsp;of Regulation M under the Exchange Act are not
satisfied with respect to us or our Class&nbsp;A Common Stock, we or the Agents, as applicable, are required by the Sales Agreement to
notify the other parties and sales of Class&nbsp;A Common Stock under the Sales Agreement must be suspended until that or other exemptive
provisions have been satisfied in the judgment of each party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The offering of Class&nbsp;A
Common Stock pursuant to the Sales Agreement will terminate upon the earlier of (i)&nbsp;the sale of Class&nbsp;A Common Stock with an
aggregate offering price of $1,000,000,000 pursuant to the Sales Agreement or (ii)&nbsp;the termination of the Sales Agreement by the
Agents or us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Commissions and Expenses</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We will pay the Agents a
commission equal to 1.5% of the gross sales price of shares of Class&nbsp;A Common Stock sold through it or to them as sales agent under
the Sales Agreement. The remaining sales proceeds, after deducting any transaction fees, transfer taxes or other similar fees, taxes
or charges imposed by any governmental, regulatory or self-regulatory organization in respect of such sales and other expenses relating
to the sale of shares offered hereby payable by us, will equal our net proceeds for the sale of the shares. We have agreed to reimburse
the Agents for certain expenses incurred by them in connection with the sale of shares offered hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We estimate that expenses
payable by us in connection with this offering (other than any commissions and expense reimbursement payable to the Agents under the
Sales Agreement) will be approximately $2 million through the date of this prospectus supplement, and we expect to incur additional expenses
(in addition to any such commissions and expense reimbursement) in connection with this offering in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Indemnification</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In connection with the sale
of our Class&nbsp;A Common Stock on our behalf, the Agents may be deemed to be &ldquo;underwriters&rdquo; within the meaning of the Securities
Act and the compensation paid to the Agents may be deemed to be underwriting commissions or discounts. We have agreed to indemnify the
Agents against certain liabilities, including liabilities under the Securities Act and to contribute to payments that the Agents may
be required to make for these liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Stamp Taxes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If you purchase shares of
Class&nbsp;A Common Stock offered by this prospectus supplement and the accompanying prospectus, you may be required to pay stamp taxes
and other charges under the laws and practices of the country of purchase, in addition to the purchase price payable for those shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Conflicts of Interest</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Certain of the Agents and/or
their affiliates may hold our 2.25% convertible notes with an aggregate principal amount of $402.5 million due 2030 and 0% convertible
notes with an aggregate principal amount of $805.0 million due 2032 (the &ldquo;Notes&rdquo;), and may receive a portion of the net proceeds
from the sale of shares of our Class&nbsp;A Common Stock if we use such proceeds to repurchase or repay the Notes. Because of this relationship,
they may be deemed to have a &ldquo;conflict of interest&rdquo; under Rule&nbsp;5121 (&ldquo;Rule&nbsp;5121&rdquo;) of the Financial
Industry Regulatory Authority,&nbsp;Inc. (&ldquo;FINRA&rdquo;). Therefore, the offering will be made in compliance with such rule. In
accordance with that rule, no &ldquo;qualified independent underwriter&rdquo; is required, because a bona fide public market exists in
the shares, as that term is defined in the rule. If the offering is conducted in accordance with FINRA&rsquo;s Rule&nbsp;5121, such Agents
would not be permitted to confirm a sale to an account over which they exercise discretionary authority without first receiving specific
written approval from the account holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Other Relationships</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Agents and certain of
their affiliates are full service financial institutions engaged in various activities, which may include securities trading, commercial
and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and
brokerage activities. The Agents and certain of their affiliates have, from time to time, performed, and may in the future perform, various
commercial and investment banking and financial advisory services for the issuer and its affiliates, for which they received or may in
the future receive customary fees and expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the ordinary course of
their various business activities, the Agents and certain of their affiliates may make or hold a broad array of investments and actively
trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account
and for the accounts of their customers, and such investment and securities activities may involve securities and/or instruments of the
issuer or its affiliates. The Agents and certain of their affiliates may also communicate independent investment recommendations, market
color or trading ideas and/or publish or express independent research views in respect of such securities or instruments and may at any
time hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="ka_009"></A><B>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The validity of the securities
we are offering will be passed upon by O&rsquo;Melveny&nbsp;&amp; Myers LLP. The Agents are being represented in connection with this
offering by Vinson&nbsp;&amp; Elkins LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ka_010"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The financial statements
of Centrus Energy Corp. as of December&nbsp;31, 2024 and 2023, and for each of the two years in the period ended December&nbsp;31, 2024,
incorporated by reference in this prospectus supplement by reference to Centrus Energy Corp.&rsquo;s <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000006/leu-20241231.htm" STYLE="-sec-extract: exhibit">annual
report on Form&nbsp;10-K for the year ended December&nbsp;31, 2024</A>, and the effectiveness of Centrus Energy Corp.&rsquo;s internal
control over financial reporting have been audited by Deloitte&nbsp;&amp; Touche LLP, an independent registered public accounting firm,
as stated in their reports. Such financial statements are incorporated by reference in reliance upon the reports of such firm given their
authority as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The financial statements
for the year ended December&nbsp;31, 2022 incorporated in this prospectus supplement by reference to the <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000006/leu-20241231.htm" STYLE="-sec-extract: exhibit">Annual
Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2024</A> have been so incorporated in reliance on the report of PricewaterhouseCoopers
LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="ka_011"></A><B>WHERE YOU CAN FIND MORE
INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have filed with the SEC
a registration statement on Form&nbsp;S-3 under the Securities Act with respect to the Class&nbsp;A Common Stock offered hereby. This
prospectus supplement does not contain all of the information set forth in the registration statement and the exhibits and schedules
thereto. For further information with respect to the Company and its Class&nbsp;A Common Stock, reference is made to the registration
statement and the exhibits and any schedules filed therewith. Statements contained in this prospectus supplement as to the contents of
any contract or other document referred to are not necessarily complete and in each instance, if such contract or document is filed as
an exhibit, reference is made to the copy of such contract or other document filed as an exhibit to the registration statement, each
statement being qualified in all respects by such reference. The SEC maintains an Internet site at <I>http://www.sec.gov</I>, from which
interested persons can electronically access the registration statement, including the exhibits and any schedules thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are subject to the information
reporting requirements of the Exchange Act, and we file periodic reports and other information with the SEC. All documents filed with
the SEC are available for inspection and copying at the addresses set forth above. We also maintain an Internet site at www.centrusenergy.com.
Our website and the information contained therein or connected thereto shall not be deemed to be incorporated into this prospectus supplement
or the registration statement of which it forms a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ka_012"></A>INCORPORATION OF CERTAIN
DOCUMENTS BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The SEC allows us to &ldquo;incorporate
by reference&rdquo; the information we file with them which means that we can disclose important information to you by referring you
to those documents instead of having to repeat the information in this prospectus supplement. The information incorporated by reference
is considered to be part of this prospectus supplement, and later information that we file with the SEC will automatically update and
supersede this information. This prospectus supplement incorporates by reference the documents listed below (other than, unless otherwise
specifically indicated, current reports furnished under Item 2.02,&nbsp;Item 7.01 or Item 9.01 of Form&nbsp;8-K and exhibits filed on
such form that are related to such items):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000006/leu-20241231.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2024, filed with the SEC on February&nbsp;7, 2025;</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the information specifically
    incorporated by reference into our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000006/leu-20241231.htm">Annual
    Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2025</A> from our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000110465925039220/tm252408-1_def14a.htm" STYLE="-sec-extract: exhibit">Definitive
    Proxy Statement on Schedule 14A, filed with the SEC on April&nbsp;25, 2025</A>; </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Quarterly Reports on
    Form&nbsp;10-Q for the fiscal quarter ended March&nbsp;31, 2025, filed with the SEC on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000024/leu-20250331.htm" STYLE="-sec-extract: exhibit">May&nbsp;8,
    2025</A>, the fiscal quarter ended June&nbsp;30, 2025, filed with the SEC on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000058/leu-20250630.htm" STYLE="-sec-extract: exhibit">August&nbsp;6,
    2025</A>, and the fiscal quarter ended September&nbsp;30, 2025, filed with the SEC on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000162828025049844/leu-20250930.htm">November&nbsp;6, 2025</A>; </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">our Current Reports on Form 8-K filed with the SEC
    on </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000011/leu-20250224.htm"><FONT STYLE="font-size: 10pt">February
    25, 2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000110465925046727/tm2514262d1_8k.htm"><FONT STYLE="font-size: 10pt">May
    9, 2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000032/leu-20250605.htm"><FONT STYLE="font-size: 10pt">June
    6, 2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000035/leu-20250617.htm"><FONT STYLE="font-size: 10pt">June
    20, 2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000037/leu-20250620.htm"><FONT STYLE="font-size: 10pt">June
    20, 2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000053/leu-20250625.htm"><FONT STYLE="font-size: 10pt">June
    25, 2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000061/leu-20250807.htm"><FONT STYLE="font-size: 10pt">August
    8, 2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000162828025039978/leu-20250812.htm"><FONT STYLE="font-size: 10pt">August
    13, 2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000072/leu-20250813.htm"><FONT STYLE="font-size: 10pt">August
    14, 2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000075/leu-20250818.htm"><FONT STYLE="font-size: 10pt">August
    18, 2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000078/leu-20250804.htm"><FONT STYLE="font-size: 10pt">August
    19, 2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000081/leu-20250821.htm"><FONT STYLE="font-size: 10pt">August
    22, 2025</FONT></A><FONT STYLE="font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000083/leu-20250825.htm"><FONT STYLE="font-size: 10pt">August
    26, 2025</FONT></A><FONT STYLE="font-size: 10pt">, and </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000162828025042699/leu-20250925.htm"><FONT STYLE="font-size: 10pt">September
    25, 2025</FONT></A><FONT STYLE="font-size: 10pt">; and</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the description of our
    common stock contained in our Registration Statement on Form&nbsp;8-A12B, filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/1065059/000106505916000072/form8-a_20160406.htm" STYLE="-sec-extract: exhibit">April&nbsp;7,
    2016</A>, including any amendment or report filed for the purpose of updating such description, including <A HREF="https://www.sec.gov/Archives/edgar/data/1065059/000106505925000006/exhibit_418x20241231xdescra.htm" STYLE="-sec-extract: exhibit">Exhibit&nbsp;4.18</A>
    of our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2024, filed with the SEC on February&nbsp;7, 2025.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">All reports and other documents
we subsequently file pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d)&nbsp;of the Exchange Act prior to the termination of this offering,
including all such documents we may file with the SEC after the date of the initial registration statement and prior to the effectiveness
of the registration statement, but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated
by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We will furnish without
charge to you, on written or oral request, a copy of any or all of the documents incorporated by reference, including exhibits to these
documents. You should direct any requests for documents in writing to: Centrus Energy Corp., 6901 Rockledge Drive, Suite&nbsp;800, Bethesda,
MD 20817, tel: (301) 564-3200. These documents are also available on the Investors section of our website, which is located at www.centrusenergy.com,
or as described under &ldquo;Where You Can Find Additional Information&rdquo; above. The reference to our website address does not constitute
incorporation by reference of the information contained on our website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">You should rely only on
information contained in, or incorporated by reference into, this prospectus supplement. We have not authorized anyone to provide you
with information different from that contained in this prospectus supplement or incorporated by reference in this prospectus supplement.
We are not making offers to sell the securities in any jurisdiction in which such an offer or solicitation is not authorized or in which
the person making such offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make such offer or solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2530029d1_s3asrimg001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 24pt"><B>Centrus Energy
Corp.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Common Stock</B></FONT></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Preferred Stock</B></FONT></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Debt Securities</B></FONT></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Warrants</B></FONT></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Rights</B></FONT></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Units</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">From
time to time, we may offer and sell the securities described in this prospectus</FONT> separately or together in any combination, in
one or more classes or series, in amounts, at prices and on terms that we will determine at the time of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus provides a
general description of the securities we may offer. We may provide specific terms of securities to be offered in one or more supplements
to this prospectus. We may also provide a specific plan of distribution for any securities to be offered in a prospectus supplement. Prospectus
supplements may also add, update or change information in this prospectus. You should carefully read this prospectus and the applicable
prospectus supplement, together with any documents incorporated by reference herein, before you invest in our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Our
common stock is listed on The NYSE American LLC, or the NYSE American, under the symbol &ldquo;LEU.&rdquo; On November 5</FONT>, 2025,
the last reported sale price of our common stock was $<FONT>325.73</FONT> per share. The applicable prospectus
supplement will contain information, where applicable, as to the listing of any other securities covered by the prospectus supplement
other than our common stock on the NYSE American or any other securities exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Investing
in any of our securities involves a high degree of risk. Please read carefully the section entitled &ldquo;Risk Factors&rdquo; on page&nbsp;</B></FONT><B>9</B>
<B>of this prospectus, the &ldquo;Risk Factors&rdquo; section contained in the applicable prospectus supplement and the information included
and incorporated by reference in this prospectus.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The date of this prospectus is November&nbsp;6,
2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Page</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%; text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a_001">About This Prospectus</A></TD>
    <TD STYLE="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0in"><A HREF="#a_001">1</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a_002">Where You Can Find More Information</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><A HREF="#a_002">2</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a_003">Information We Incorporate By Reference</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><A HREF="#a_003">3</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a_004">Special Note Regarding Forward-Looking Statements</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><A HREF="#a_004">4</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a_005">Centrus Energy Corp.</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><A HREF="#a_005">8</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a_006">Risk Factors</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><A HREF="#a_006">9</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a_007">Use Of Proceeds</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><A HREF="#a_007">10</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a_008">Description Of Capital Stock</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><A HREF="#a_008">11</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a_009">Description Of Debt Securities</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><A HREF="#a_009">13</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a_010">Description Of Warrants</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><A HREF="#a_010">19</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a_011">Description Of Rights</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><A HREF="#a_011">22</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a_012">Description Of Units</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><A HREF="#a_012">23</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a_013">Plan Of Distribution</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><A HREF="#a_013">24</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a_014">Legal Matters</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><A HREF="#a_014">26</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a_015">Experts</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"><A HREF="#a_015">26</A></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_001"></A>About
This Prospectus</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus is part of
a registration statement on Form&nbsp;S-3 that we filed with the Securities and Exchange Commission, or the SEC, as a &ldquo;well-known
seasoned issuer&rdquo; as such term is defined in Rule&nbsp;405 of the Securities Act of 1933, as amended, or the Securities Act, using
a &ldquo;shelf&rdquo; registration or continuous offering process. Under this shelf registration process, we may, from time to time, offer
and sell any combination of the securities described in this prospectus in one or more offerings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus provides a
general description of the securities we may offer. We may provide specific terms of securities to be offered in one or more supplements
to this prospectus. We may also provide a specific plan of distribution for any securities to be offered in a prospectus supplement. Prospectus
supplements may also add, update or change information in this prospectus. If the information varies between this prospectus and the accompanying
prospectus supplement, you should rely on the information in the accompanying prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Before purchasing any securities,
you should carefully read both this prospectus and any prospectus supplement, together with the additional information described under
the heading &ldquo;Information We Incorporate by Reference.&rdquo; You should rely only on the information contained or incorporated by
reference in this prospectus, any prospectus supplement and any free writing prospectus prepared by or on behalf of us or to which we
have referred you. We have not authorized any other person to provide you with different information. If anyone provides you with different
or inconsistent information, you should not rely on it. We take no responsibility for, and can provide no assurance as to the reliability
of, any other information that others may give you. You should assume that the information contained in this prospectus, any prospectus
supplement or any free writing prospectus is accurate only as of the date on its respective cover, and that any information incorporated
by reference is accurate only as of the date of the document incorporated by reference, unless we indicate otherwise. Our business, financial
condition, results of operations and prospects may have changed since those dates. This prospectus contains summaries of certain provisions
contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the
summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed,
will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you
may obtain copies of those documents as described below under the heading &ldquo;Where You Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus and any applicable
prospectus supplement do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered
securities to which they relate. We are not making offers to sell common stock or any other securities described in this prospectus in
any jurisdiction in which an offer or solicitation is not authorized or in which we are not qualified to do so or to anyone to whom it
is unlawful to make an offer or solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise expressly
indicated or the context otherwise requires, we use the terms &ldquo;Centrus,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo;
 &ldquo;our&rdquo; or similar references to refer to Centrus Energy Corp., a Delaware corporation, and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_002"></A>Where
You Can Find More Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have filed our registration
statement on Form&nbsp;S-3 with the SEC under the Securities Act. We also file annual, quarterly and current reports, proxy statements
and other information with the SEC. Such annual, quarterly and current reports, proxy statements and other information, as well as the
registration statement, including the exhibits and any schedules thereto, are available on the Internet website maintained by the SEC
at <I>http://www.sec.gov</I>. These documents may also be accessed on our website under the heading &ldquo;Investor Relations&rdquo; at
www.centrusenergy.com. Information contained on our website is not incorporated by reference into this prospectus and you should not consider
information contained on our website to be part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus and any prospectus
supplement are part of a registration statement filed with the SEC and do not contain all of the information in the registration statement.
The full registration statement may be obtained from the SEC or us as indicated above. Forms of any indenture or other documents establishing
the terms of the offered securities are filed as exhibits to the registration statement or will be filed through an amendment to our registration
statement on Form&nbsp;S-3 or under cover of a Current Report on Form&nbsp;8-K and incorporated into this prospectus by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_003"></A>Information
We Incorporate By Reference</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC allows us to &ldquo;incorporate
by reference&rdquo; into this prospectus the information we file with it, which means that we can disclose important information to you
by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus. Any statement
contained herein or in a document incorporated or deemed to be incorporated by reference into this document will be deemed to be modified
or superseded for purposes of the document to the extent that a statement contained in this document or any other subsequently filed document
that is deemed to be incorporated by reference into this document modifies or supersedes the statement. We incorporate by reference in
this prospectus the following information (other than, in each case, documents or information deemed to have been furnished and not filed
in accordance with SEC rules):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000006/leu-20241231.htm" STYLE="-sec-extract: exhibit">Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2024, filed with the SEC on February&nbsp;7, 2025</A></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the information specifically incorporated by
reference into our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000006/leu-20241231.htm" STYLE="-sec-extract: exhibit">Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2024</A> from our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000110465925039220/tm252408-1_def14a.htm">Definitive Proxy Statement on Schedule 14A, filed with the SEC on April&nbsp;25,2025</A></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our
Quarterly Reports on Form&nbsp;10-Q for the fiscal quarter ended March&nbsp;31, 2025, filed with the SEC on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000024/leu-20250331.htm">May&nbsp;8,
2025</A>, the fiscal quarter ended June&nbsp;30, 2025, filed with the SEC on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000058/leu-20250630.htm">August&nbsp;6,
2025</A>, and the fiscal quarter ended September&nbsp;30, 2025, filed with the SEC on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000162828025049844/leu-20250930.htm">November&nbsp;6, 2025</A>;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our Current Reports on Form&nbsp;8-K, filed
                                                                                                                               with the SEC on </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000011/leu-20250224.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">February&nbsp;25,
                                                                                                                               2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000110465925046727/tm2514262d1_8k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">May&nbsp;9,
                                                                                                                               2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000032/leu-20250605.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">June&nbsp;6,
                                                                                                                               2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000035/leu-20250617.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">June&nbsp;20,
                                                                                                                               2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000037/leu-20250620.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">June&nbsp;20,
                                                                                                                               2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000053/leu-20250625.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">June&nbsp;25,
                                                                                                                               2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000061/leu-20250807.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">August&nbsp;8,
                                                                                                                               2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000162828025039978/leu-20250812.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">August&nbsp;13,
                                                                                                                               2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000072/leu-20250813.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">August&nbsp;14,
                                                                                                                               2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000075/leu-20250818.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">August&nbsp;18,
                                                                                                                               2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000078/leu-20250804.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">August&nbsp;19,
                                                                                                                               2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000081/leu-20250821.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">August&nbsp;22,
                                                                                                                               2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif">, </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000106505925000083/leu-20250825.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">August&nbsp;26,
                                                                                                                               2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif">, and </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001065059/000162828025042699/leu-20250925.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">September&nbsp;25,
                                                                                                                               2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif">;<SUP></SUP> and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the description of our common stock contained
in our Registration Statement on <A HREF="https://www.sec.gov/Archives/edgar/data/1065059/000106505916000072/form8-a_20160406.htm">Form&nbsp;8-A12B, filed with the SEC on April&nbsp;7, 2016</A></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">, including any amendment or report filed for the purpose of updating
such description, including <A HREF="https://www.sec.gov/Archives/edgar/data/1065059/000106505925000006/exhibit_418x20241231xdescra.htm">Exhibit&nbsp;4.18</A> of our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2024, filed
with the SEC on </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">February&nbsp;7,
2025</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also incorporate by reference
each of the documents that we file with the SEC under Sections 13(a), 13(c), 14 or 15(d)&nbsp;of the Securities Exchange Act of 1934,
as amended, or the Exchange Act, on or after the date of this prospectus and prior to the termination of the offerings under this prospectus
and any prospectus supplement. These documents include periodic reports, such as Annual Reports on Form&nbsp;10-K, Quarterly Reports on
Form&nbsp;10-Q and Current Reports on Form&nbsp;8-K, as well as proxy statements. We will not, however, incorporate by reference in this
prospectus any documents or portions thereof that are not deemed &ldquo;filed&rdquo; with the SEC, including any information furnished
pursuant to Item 2.02 or Item 7.01 of our Current Reports on Form&nbsp;8-K after the date of this prospectus unless, and except to the
extent, specified in such Current Reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will provide to each person,
including any beneficial owner, to whom a prospectus (or a notice of registration in lieu thereof) is delivered a copy of any of these
filings (other than an exhibit to these filings, unless the exhibit is specifically incorporated by reference as an exhibit to this prospectus)
at no cost, upon a request to us by writing or telephoning us at the following address and telephone number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Centrus Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">6901 Rockledge Drive, Suite&nbsp;800</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Bethesda, MD 20817</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(301) 564-3200</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_004"></A>Special
Note Regarding Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus, including
the documents incorporated by reference herein, may contain or incorporate &ldquo;forward-looking statements&rdquo; within the meaning
of Section&nbsp;21E of the Securities Exchange Act of 1934 as amended, and the Private Securities Litigation Reform Act of 1995. In this
context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial
performance, and often contain words such as &ldquo;expects&rdquo;, &ldquo;anticipates&rdquo;, &ldquo;intends&rdquo;, &ldquo;plans&rdquo;,
 &ldquo;believes&rdquo;, &ldquo;will&rdquo;, &ldquo;should&rdquo;, &ldquo;could&rdquo;, &ldquo;would&rdquo; or &ldquo;may&rdquo; and other
words of similar meaning. These forward-looking statements are based on information available to us as of the date of this prospectus
and represent management&rsquo;s current views and assumptions with respect to future events and operational, economic and financial performance.
Forward-looking statements are not guarantees of future performance, events or results and involve known and unknown risks, uncertainties
and other factors, which may be beyond our control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For Centrus, particular risks
and uncertainties (hereinafter, &ldquo;risks&rdquo;) that could cause our actual future results to differ materially from those expressed
in our forward-looking statements and which are, and may be, exacerbated by any worsening of the global business and economic environment
include, but are not limited to, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Risks
related to the war in Ukraine factors</B></FONT>&nbsp;primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">risks related to the geopolitical conflicts and the imposition of sanctions or other measures, including
bans or tariffs, by (i)&nbsp;the U.S. or foreign governments and institutions such as the European Union, (ii)&nbsp;organizations (including
the United Nations or other international organizations), and/or (iii)&nbsp;entities (including private entities or persons), that could
directly or indirectly impact our financial position or ability to obtain, deliver, transport, or sell low-enriched uranium (&ldquo;LEU&rdquo;)
or the separate work units (&ldquo;SWU&rdquo;) and natural uranium hexafluoride components of LEU delivered to us under the TENEX Supply
Contract or other supply contracts or make related payments or deliveries of natural uranium hexafluoride to TENEX, Joint Stock Company
(&ldquo;TENEX&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">risks related to laws or other government measures that ban, delay or restrict (i)&nbsp;imports of Russian
LEU into the United States, including but not limited to the Prohibiting Russian Uranium Imports Act (the &ldquo;Import Ban Act&rdquo;),
or (ii)&nbsp;transactions with Rosatom or its subsidiaries, which include TENEX, or (iii)&nbsp;exports of Russian LEU from Russia to the
United States or any entity that is a U.S. entity or that transacts with a U.S. entity, including but not limited to Russian Federal Decree
No.&nbsp;1544 (the &ldquo;Russian Decree&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">risks related to our potential inability to secure additional U.S. government waivers from the Import
Ban Act in a timely manner or at all in order to allow us to continue importing Russian LEU under the TENEX Supply Contract or implementing
the TENEX Supply Contract;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">risks related to TENEX&rsquo;s refusal or its prohibition or inability to deliver, or timely deliver,
LEU to us for any reason, including (i)&nbsp;U.S. or foreign government sanctions, bans, or decrees imposed on LEU from Russia or on TENEX,
(ii)&nbsp;TENEX being unable, prohibited or unwilling to receive payments, receive the return of natural uranium hexafluoride, or conduct
other activities related to the TENEX Supply Contract, (iii)&nbsp;TENEX elects, or is directed (including by its owner or the Russian
government), to limit, pause or stop transactions with us or with the United States or other countries or (iv)&nbsp;TENEX is unable to
secure specific export licenses from the Russian authorities as required by the Russian Decree for each shipment or secure them in a timely
manner to ship Russian LEU to the United States, or such export licenses, once secured, are subsequently rescinded prior to shipment;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">risks related to laws, sanctions or other government measures that prohibit or restrict doing business
with TENEX; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">risks related to disputes with third parties, including contractual counterparties, that could result
if we do not receive timely deliveries of LEU under the TENEX Supply Contract and are unable to rely on contractual protections.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Risks related
to economic and industry factors</B></FONT>&nbsp;primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to our dependence on others, such as TENEX, under the TENEX Supply Contract, Orano, under
the Orano Supply Agreement, and other suppliers (including, but not limited to, transporters, fabricators or converters) who provide,
or deliver, to us the goods and services we need to conduct our business and any resulting negative impact on our liquidity;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to our ability to sell, transport or deliver the LEU we procure pursuant to our purchase
obligations under our supply agreements and the impacts of sanctions or limitations on imports of such LEU, including those imposed under
the 1992 Russian Suspension Agreement, international trade legislation and other international trade restrictions including but not limited
to the Import Ban Act and Russian Decree;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to the increasing quantities of LEU being imported into the United States from China and
the impact on our ability to make future LEU or SWU sales or ability to finance any build-out of our enrichment capacities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to change in laws, tariffs or other government measures that would lift, lower or relax
such laws, tariffs or government measures to allow the importation of LEU, or increase its cost, from Russia or other countries with restrictions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to not being able to sell the Russian LEU available for purchase under the TENEX Supply
Contract for import in 2026 or 2027 for any reason, including customers having filled their fuel needs for those years;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to whether or when government funding or demand for high assay low-enriched uranium (&ldquo;HALEU&rdquo;)
for government or commercial uses will materialize and at what level;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks regarding funding for continuation and deployment of the American Centrifuge technology;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to (i)&nbsp;our ability to perform and absorb costs under the HALEU Operation Contract,
(ii)&nbsp;our ability to obtain new contracts and funding to be able to continue operations and (iii)&nbsp;our ability to obtain and/or
perform under other agreements;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks that (i)&nbsp;we may not obtain the full benefit of the HALEU Operation Contract and may not be
able or allowed to operate the HALEU enrichment facility to produce HALEU after the completion of the HALEU Operation Contract or (ii)&nbsp;the
output from the HALEU enrichment facility may not be available to us as a future source of supply;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to existing or new trade barriers, and related to contract terms, that limit our ability
to procure LEU for, or sell, transport or deliver LEU to, customers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to pricing trends and demand in the uranium and enrichment markets and their impact on our
profitability;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to the movement and timing of customer orders;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to the fact that we face significant competition from major LEU producers who may be less
cost sensitive or are wholly or partially government owned;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks that our ability to compete in foreign markets may be limited for various reasons, including policies
that favor indigenous suppliers over foreign suppliers of goods and services;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to the fact that our revenue is largely dependent on our largest customers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to our backlog, including uncertainty concerning customer actions under current contracts
and in future contracting attributable to market conditions, global events or other factors, including our lack of current production
capability;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to natural and other disasters, including the continued impact of the March&nbsp;2011 earthquake
and tsunami in Japan, on the nuclear industry and on our business, results of operations and prospects;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to financial difficulties experienced by customers or suppliers, including possible bankruptcies,
insolvencies, or any other situation, event or occurrence that affect the ability of others to pay for our products or services in a timely
manner or at all;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to pandemics, endemics, and other health crises; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify">risks related to the impact and potential extended duration of a supply/demand imbalance in the market
for LEU.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Risks related
to operational factors</B></FONT>&nbsp;primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to the U.S. Department of Energy (&ldquo;DOE&rdquo;)
not issuing any major task orders to any contract awardee under any of the HALEU Production Contract, LEU Production Contract, or HALEU
Deconversion Contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to the Company not winning additional task orders
under the HALEU Production Contract, LEU Production Contract and HALEU Deconversion Contract to expand the capacity of the American Centrifuge
plant;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to DOE not providing an adequate share of the appropriated
funding to the Company under any of the HALEU Production Contract, LEU Production Contract, or HALEU Deconversion Contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to our ability to secure financing to expand our plant
for LEU or HALEU or expand it to the level that would make it commercially viable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to the DOE not exercising additional options under
Phase 3 of the HALEU Operation Contract or awarding a third party to continue the HALEU Operation Contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to our inability to increase capacity for HALEU or
LEU in a timely manner to meet market demand or our contractual obligations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to DOE not awarding any contracts to the Company in
response to the Company&rsquo;s future proposals;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to reliance on the only firm that has the necessary
permits and capability to transport LEU from Russia to the United States and that firm&rsquo;s ability to maintain those permits and capabilities
or secure additional permits;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to the ongoing government shutdown or lack of funding
that could result in program cancellations, disruptions and/or stop work orders and could limit the U.S. government&rsquo;s ability to
make timely payments, including under Executive Order 14158, and our ability to perform under our U.S. government contracts and successfully
compete for work including under the HALEU Operation Contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to changes to the U.S. government&rsquo;s appropriated
funding levels for HALEU Operation Contract due to changes in U.S. government policy or other reasons;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to uncertainty regarding our ability to commercially
deploy competitive enrichment technology;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to the potential for demobilization or termination
of the HALEU Operation Contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks that we will not be able to timely complete the work that
we are obligated to perform;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to the government&rsquo;s inability to satisfy its
obligations, including supplying government furnished equipment necessary for us to produce and deliver HALEU under the HALEU Operation
Contract and processing security clearance applications resulting from a government shutdown or other reasons;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to our inability to obtain the government&rsquo;s
approval to extend the term of, or the scope of permitted activities under, our lease with the DOE in Piketon, Ohio;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to security, including cybersecurity, incidents that
may impact our business operations, including incidents that may relate to the ongoing conflict in the Middle East and other regions of
concern;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to our inability to perform under fixed-price and
cost-share contracts such as the HALEU Operation Contract, including the risk that costs that we must incur could be higher than expected
and the risk related to complying with stringent government contractual requirements; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to our inability to attract qualified employees necessary
for the planned expansion of our operations in Oak Ridge, Tennessee or Piketon, Ohio.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Risks related
to financial factors</B></FONT>&nbsp;primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to our long-term liabilities, including our defined
benefit pension plan obligations and postretirement health and life benefit obligations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to our 0% and 2.25% Convertible Notes maturing in
2032 and 2030, respectively;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks of revenue and operating results fluctuating significantly
from quarter to quarter, and in some cases, year to year;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to the impact of financial market conditions on our
business, liquidity, prospects, pension assets and insurance facilities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to the Company&rsquo;s capital concentration;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to the value of our intangible assets related to LEU
segment&rsquo;s backlog and customer relationships;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to decisions made by our Class&nbsp;B Common Stock
stockholders regarding their investment in the Company, including decisions based upon factors that are unrelated to the Company&rsquo;s
performance;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks that a small number of holders of our Class&nbsp;A Common
Stock (whose interests may not be aligned with other holders of our Class&nbsp;A Common Stock) may exert significant influence over the
direction of the Company and may be motivated by interests that are not aligned with the Company&rsquo;s other Class&nbsp;A stockholders;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to (i)&nbsp;the use of our net operating loss (&ldquo;NOL&rdquo;)
carryforwards and net unrealized built in losses (&ldquo;NUBILs&rdquo;) to offset future taxable income and the use of the Rights Agreement
to prevent an &ldquo;ownership change&rdquo; as defined in Section&nbsp;382 of the Internal Revenue Code and (ii)&nbsp;our ability to
generate taxable income to utilize all or a portion of the NOLs prior to the expiration thereof and NUBILs; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to failures or security, including cybersecurity,
breaches of our information technology systems.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Risks related
to general factors</B></FONT>&nbsp;primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to our ability to attract and retain key personnel;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks that we will be unable to obtain new business opportunities
or achieve market acceptance of our products and services or that products or services provided by others will render our products or
services obsolete or noncompetitive;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to actions, including investigations, reviews or audits,
that may be taken by the U.S. government, the Russian government, or other governments that could affect our ability to perform under
our contractual obligations or the ability of our sources of supply to perform under their contractual obligations to us;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to our inability to perform and receive timely payment
under our agreements with the DOE or other government agencies, including risks related to the ongoing funding by the government and potential
audits;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to how aligned we may be, or perceived to be, with
any political party, administration, or its policies based on our positions or our political action committee&rsquo;s advocacy;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to changes or termination of our agreements with the
U.S. government or other counterparties, or the exercise of contract remedies by such counterparties, or U.S. government rights in our
intellectual property based on such agreements;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to the competitive environment for our products and
services;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to changes in the nuclear energy industry;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to the competitive bidding process associated with
obtaining contracts, including government contracts; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to potential strategic transactions that could be
difficult to implement, that could disrupt our business or that could change our business profile significantly.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Risks related
to legal and compliance factors</B></FONT>&nbsp;primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to the outcome of legal proceedings and other contingencies
(including lawsuits and government investigations or audits);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to the impact of, or changes to, government regulation
and policies or interpretation of laws or regulations, including by the DOE, the U.S. Department of Commerce and the </FONT>U.S. Nuclear
Regulatory Commission <FONT STYLE="background-color: white">(&ldquo;NRC&rdquo;);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks related to the recent U.S. federal government administration&rsquo;s
reliance on executive orders to implement regulatory or trade policy and objectives, which could exacerbate regulatory or, private or
public, financing unpredictability;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks of accidents during the transportation, handling, or processing
of toxic hazardous or radioactive material that may pose a health risk to humans or animals, cause property or environmental damage, or
result in precautionary evacuations, and lead to claims against the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks associated with claims and litigation arising from past activities
at sites we currently operate or past activities at sites that we no longer operate, including the Paducah GDP and Portsmouth GDP; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">other risks discussed in this and our other filings with the SEC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These factors may not constitute
all factors that could cause actual results or events to differ from those discussed in any forward-looking statement. Other risks and
uncertainties not presently known to us or that we presently believe are not material could also cause actual results or events to differ
materially from those expressed in the forward-looking statements contained in this prospectus. All forward-looking statements in this
prospectus, any accompanying prospectus supplement and the documents incorporated by reference herein or therein are qualified by these
cautionary statements and are only made as of the date of this prospectus, the date of such accompanying prospectus supplement or the
date of the document incorporated by reference herein or therein, as the case may be. The forward-looking statements in this prospectus,
any accompanying prospectus supplement and the documents incorporated by reference herein or therein should be evaluated together with
the many risks and uncertainties that affect our business, particularly those discussed in greater detail under the heading &ldquo;Risk
Factors&rdquo; in this prospectus, in accompanying prospectus supplement and in our most recent Annual Report on Form&nbsp;10-K filed
with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We disclaim any obligation
or undertaking, other than as required by law, to provide any updates or revisions to any forward-looking statement to reflect any change
in our expectations or any change in events, conditions or circumstances on which the forward-looking statement is based, whether as a
result of new information, future events or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_005"></A>Centrus
Energy Corp.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Centrus is a trusted supplier
of nuclear fuel components for the nuclear power industry, which provides a reliable source of carbon free energy and provides enrichment
and technical services for public and private customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Centrus operates two business
segments: (a)&nbsp;LEU, which supplies various components of nuclear fuel to commercial customers from our global network of suppliers,
and (b)&nbsp;Technical Solutions, which provides advanced uranium enrichment for the nuclear industry and the U.S. government and advanced
manufacturing and other technical services to government and private sector customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our LEU segment provides most
of the Company&rsquo;s revenue and involves the sale of enriched uranium, the fissile component of nuclear fuel, primarily to utilities
that operate commercial nuclear power plants. The majority of these sales are for the enrichment component of LEU, which is measured in
SWU. Centrus also sells natural uranium hexafluoride (the raw material needed to produce LEU) and occasionally sells uranium concentrates,
uranium conversion, or LEU with the natural uranium hexafluoride and SWU components combined into one sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">LEU is a critical component
in the production of nuclear fuel for reactors that produce electricity. We supply LEU and its components to both domestic and international
utilities for use in nuclear reactors worldwide. We provide LEU from multiple sources, including medium- and long-term supply contracts,
spot purchases and our inventory. As a long-term supplier of LEU to our customers, our objective is to provide value through the reliability
and diversity of our supply sources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Published spot price indicators
for SWU reached previous historic highs in April&nbsp;2009 at $163 per SWU. In the years following the 2011 Fukushima accident in Japan,
spot prices declined more than 75%, bottoming out in August&nbsp;2018 at $34 per SWU. This was followed by a period of price increases,
which reached $195 per SWU by December&nbsp;31, 2024, which surpassed the previous historic high. As of September&nbsp;30, 2025, spot
prices were $220 per SWU. This represents an increase of 13% since the beginning of the year and an increase of 547% over the 2018 historic
low. This surge in the SWU spot price beginning in 2022 has been driven primarily by uncertainty created as a result of the war in Ukraine,
coupled with growing interest in nuclear power as a source of reliable carbon-free energy. The contemplation of the imposition of tariffs
on LEU, if ultimately imposed, may put additional upward pressure on the price of SWU.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When Russian supply is included,
the uranium enrichment segment of the global nuclear fuel market is oversupplied. But without Russian supply, the global market for uranium
enrichment would be undersupplied. Further, it is not clear that there are sufficient inventories of enriched uranium in the United States
to compensate for a loss of Russian supply, absent new capacity that will take a number of years to deploy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Changes in the supply-demand
balance and in the competitive landscape arising from the war in Ukraine or the imposition of tariffs, may affect pricing trends, change
customer spending patterns, and create additional uncertainty in the uranium market. At the same time, uncertainty remains about future
demand for nuclear power generation. To address such changes and uncertainty, we continue to evaluate opportunities to grow our business
organically or through acquisitions and other strategic transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Technical Solutions segment
is committed to the restoration of America&rsquo;s domestic uranium enrichment production capability in order to play a critical role
in meeting U.S. national security and energy security requirements and advancing America&rsquo;s nonproliferation, energy, and climate
objectives. Our Technical Solutions segment is also focused on repairing broken and vulnerable supply chains, providing clean energy jobs,
and supporting the communities in which we operate. Our goal is to deliver major components of the next-generation nuclear fuels that
will provide reliable carbon-free power around the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are also actively considering
and expect to consider potential strategic transactions from time to time, which could involve, without limitation, acquisitions and/or
dispositions of businesses or assets, joint ventures or investments in businesses, products or technologies or changes to our capital
structure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our principal executive office
is located at 6901 Rockledge Drive, Suite&nbsp;800, Bethesda, Maryland 20817, and our telephone number is (301) 564-3200. Our website
is www.centrusenergy.com. However, the information located on, or accessible from, our website is not, and should not be deemed to be,
part of this prospectus, any accompanying prospectus supplement or any free writing prospectus or incorporated into any other filing that
we submit to the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_006"></A>Risk
Factors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investing in our securities
involves a high degree of risk. Before making an investment decision, you should carefully consider any risk factors set forth in the
applicable prospectus supplement and the documents incorporated by reference in this prospectus, including the factors discussed under
the heading &ldquo;Risk Factors&rdquo; in our most recent Annual Report on Form&nbsp;10-K and each subsequently filed Quarterly Report
on Form&nbsp;10-Q and any risk factors set forth in our other filings with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d)&nbsp;of
the Securities Exchange. See &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Information We Incorporate By Reference.&rdquo;
Each of the risks described in these documents could materially and adversely affect our business, financial condition, results of operations
and prospects, and could result in a partial or complete loss of your investment. Additional risks and uncertainties not presently known
to us, or that we currently deem immaterial, may also adversely affect our business. In addition, past financial performance may not be
a reliable indicator of future performance and historical trends should not be used to anticipate results or trends in future periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_007"></A>Use
Of Proceeds<SUP></SUP></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will retain broad discretion
over the use of the net proceeds from the sale of the securities offered hereby. Unless otherwise specified in any prospectus supplement,
we currently intend to use the net proceeds from the sale of our securities offered under this prospectus for working capital and general
corporate purposes including, but not limited to, capital expenditures, working capital, repayment of indebtedness, potential acquisitions
and other business opportunities. Pending any specific application, we may initially invest funds in short-term marketable securities
or apply them to the reduction of indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_008"></A>Description
Of Capital Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The authorized capital stock
of Centrus Energy Corp. consists of (a)&nbsp;100,000,000 shares of common stock, par value $0.10 per share, of which 70,000,000 shares
are classified as Class&nbsp;A Common Stock, and 30,000,000 shares are classified as Class&nbsp;B Common Stock, and (b)&nbsp;20,000,000
shares of preferred stock, par value $1.00 per share, of which 2,000,000 shares have been designated Series&nbsp;A Participating Cumulative
Preferred Stock. The Class&nbsp;A Common Stock is registered pursuant to Section&nbsp;12 of the Securities Exchange Act of 1934, as amended,
and trades on the NYSE American platform under the symbol &ldquo;LEU.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following description
of the terms of our securities is not complete and is qualified in its entirety by reference to the Company&rsquo;s Amended and Restated
Certificate of Incorporation (the &ldquo;Certificate of Incorporation&rdquo;), the Company&rsquo;s Third Amended and Restated Bylaws (the
 &ldquo;Bylaws&rdquo;), and the Rights Agreement (as defined below), all of which are exhibits to our Annual Report on Form&nbsp;10-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Class&nbsp;A Common Stock</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of Class&nbsp;A
Common Stock are entitled to one vote for each outstanding share of Class&nbsp;A Common Stock owned by that stockholder on every matter
properly submitted to the stockholders for their vote, except for any amendment for the Certificate of Incorporation that relates solely
to the terms of one or more outstanding series of preferred stock or Class&nbsp;B Common Stock. Generally, all matters to be voted on
by stockholders, other than the election of directors, must be approved by a majority in voting power of the stock represented and entitled
to vote. However, questions governed expressly by provisions of the Certificate of Incorporation, bylaws, applicable stock exchange rules&nbsp;or
applicable law require approval as set forth in the applicable governing document, stock exchange rule&nbsp;or law. The holders of Class&nbsp;B
Common Stock are entitled to elect up to two directors, which right is subject to change based on certain holding requirements. Otherwise,
the directors are elected by a plurality of votes cast on the election of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the rights of the
holders of any series of preferred stock outstanding at any time, the holders of Class&nbsp;A Common Stock and Class&nbsp;B Common Stock
will be entitled to share ratably, based upon the number of shares held, in such dividends and other distributions of cash or any other
right or property as may be declared by the Board of Directors out of the assets or funds legally available for such dividends or distributions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of any voluntary
or involuntary liquidation, dissolution or winding up of the Company&rsquo;s affairs, holders of Class&nbsp;A Common Stock and Class&nbsp;B
Common Stock would be entitled to share ratably, based upon the number of shares held, in assets that are legally available for distribution
to stockholders after payment of liabilities. If there is any preferred stock outstanding at such time, holders of the preferred stock
may be entitled to distribution and/or liquidation preferences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Certificate of Incorporation
does not provide for any conversion, sinking fund, redemption, preference, preemptive right, or right of subscription for the Class&nbsp;A
Common Stock. Issued and outstanding shares of Class&nbsp;B Common Stock convert into shares of Class&nbsp;A Common Stock upon transfer
to a party other than the current Class&nbsp;B stockholders and their respective affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Provisions of the Company&rsquo;s Certificate of Incorporation,
Bylaws and Delaware Law that May&nbsp;Have an Anti-Takeover Effect</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><I>Certificate
of Incorporation and Bylaws.</I></FONT><B>&nbsp;</B>The Certificate of Incorporation and Bylaws provide that a special meeting of stockholders
may be called only by the Chairman, the President, the Board of Directors or a committee empowered by the Board of Directors to call a
special meeting. Stockholders are not permitted to call, or to require that the Board of Directors call, a special meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that levels of
foreign ownership of the Company&rsquo;s stock established by the Certificate of Incorporation are exceeded, the Board of Directors has
the right to take certain actions with respect to such ownership. These actions include requesting information from holders (or proposed
holders) of the Company&rsquo;s securities, refusing to permit the transfer of securities by such holders, suspending or limiting voting
rights of such holders, redeeming or exchanging shares of the Company&rsquo;s stock owned by such holders on terms set forth in the Certificate
of Incorporation, and taking other actions that are deemed necessary or appropriate to ensure compliance with the foreign ownership restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><I>Delaware
Takeover Statute.<B>&nbsp;</B></I></FONT>The Company is subject to Section&nbsp;203 of the Delaware General Corporation Law (the &ldquo;DGCL&rdquo;),
which, subject to certain exceptions, prohibits a Delaware corporation from engaging in any &ldquo;business combination&rdquo; (as defined
below) with any &ldquo;interested stockholder&rdquo; (as defined below) for a period of three years following the date that such stockholder
became an interested stockholder, unless: (i)&nbsp;prior to such date, the Board of Directors of the corporation approved either the business
combination or the transaction that resulted in the stockholder becoming an interested stockholder; (ii)&nbsp;on consummation of the transaction
that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock
of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding
those shares owned (x)&nbsp;by persons who are directors and also officers and (y)&nbsp;by employee stock plans in which employee participants
do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer;
or (iii)&nbsp;on or subsequent to such date, the business combination is approved by the Board of Directors and authorized at an annual
or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting
stock that is not owned by the interested stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;203 of the DGCL
defines &ldquo;business combination&rdquo; to include: (i)&nbsp;any merger or consolidation involving the corporation and the interested
stockholder; (ii)&nbsp;any sale, lease, exchange, mortgage, transfer, pledge or other disposition of 10% or more of the assets of the
corporation involving the interested stockholder; (iii)&nbsp;subject to certain exceptions, any transaction that results in the issuance
or transfer by the corporation of any stock of the corporation to the interested stockholder; (iv)&nbsp;any transaction involving the
corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially
owned by the interested stockholder; or (v)&nbsp;the receipt by the interested stockholder of the benefit of any loans, advances, guarantees,
pledges or other financial benefits provided by or through the corporation. In general, Section&nbsp;203 of the DGCL defines an &ldquo;interested
stockholder&rdquo; as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any
entity or person affiliated with or controlling or controlled by such entity or person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Rights to Acquire Series&nbsp;A Participating Cumulative Preferred
Stock</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&nbsp;6, 2016, Centrus
adopted a Section&nbsp;382 stockholders rights plan and declared a dividend distribution of one right for each outstanding share of our
common stock to stockholders of record on April&nbsp;6, 2016. Each right entitles its holder, under the circumstances described below,
to purchase from us one one-thousandth of a share of our Series&nbsp;A Participating Cumulative Preferred Stock, par value $1.00 per share,
at an exercise price of $160.38 per right, subject to adjustment. The terms of the rights are set forth in a Section&nbsp;382 Rights Agreement
between us, Computershare,&nbsp;Inc. and Computershare Trust Company, N.A., as amended (the &ldquo;Rights Agreement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The rights plan is intended
to act as a deterrent to any person or group, together with its affiliates and associates, being or becoming the beneficial owner of 4.99%
or more of common stock, with certain exceptions. The rights initially trade together with the common stock and are not exercisable. In
the absence of further action by the Board, the rights would generally become exercisable and allow a holder to acquire shares of a new
series of the Company&rsquo;s preferred stock if any person or group acquires 4.99% or more of the outstanding shares of the Company&rsquo;s
common stock, or if a person or group that already owned 4.99% or more of the Company&rsquo;s Class&nbsp;A Common Stock when the rights
plan was initially adopted acquires additional shares representing 0.5% or more of the outstanding shares of the Company&rsquo;s Class&nbsp;A
Common Stock. The rights beneficially owned by the acquirer would become null and void, resulting in significant dilution in the ownership
interest of such acquirer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board may exempt any acquisition
of the Company&rsquo;s common stock from the provisions of the Rights Agreement if it determines that doing so would not jeopardize or
endanger the Company&rsquo;s use of its tax assets or is otherwise in the best interests of the Company. The Board also has the ability
to amend or terminate the Rights Agreement prior to a triggering event. Unless earlier terminated or extended in accordance with the Rights
Agreement, the rights issued under the Rights Agreement expire on June&nbsp;30, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_009"></A>Description
Of Debt Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following description,
together with the additional information we include in any applicable prospectus supplement, summarizes certain general terms and provisions
of the debt securities that we may offer in one or more series under this prospectus. When we offer to sell a particular series of debt
securities, we will describe the specific terms of the series in a supplement to this prospectus. We will also indicate in the supplement
to what extent the general terms and provisions described in this prospectus apply to a particular series of debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue debt securities
either separately, or together with, or upon the conversion or exercise of or in exchange for, other securities described in this prospectus.
Debt securities may be our senior, senior subordinated or subordinated obligations and, unless otherwise specified in a supplement to
this prospectus, the debt securities will be our direct, unsecured obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will issue the debt securities
under the indenture that we will enter into with a national banking association or other eligible party, as trustee. The indenture will
be qualified under the Trust Indenture Act of 1939, as amended, or the Trust Indenture Act. We have filed the form of indenture as an
exhibit to the registration statement of which this prospectus is a part, and supplemental indentures and forms of debt securities containing
the terms of the debt securities being offered will be filed as exhibits to the registration statement of which this prospectus is a part
or will be incorporated by reference from reports that we file with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following summary of material
provisions of the debt securities and the indenture is subject to, and qualified in its entirety by reference to, all of the provisions
of the indenture applicable to a particular series of debt securities. The summary is not complete. The form of the indenture has been
filed as an exhibit to the registration statement and you should read the indenture for provisions that may be important to you. We urge
you to read the applicable prospectus supplements and any related free writing prospectuses related to the debt securities that we may
offer under this prospectus, as well as the complete indenture that contains the terms of the debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We can issue an unlimited
amount of debt securities under the indenture that may be in one or more series with the same or various maturities, at par, at a premium,
or at a discount. The terms of each series of debt securities will be established by or pursuant to a resolution of our board of directors
and set forth in an officer&rsquo;s certificate or a supplemental indenture. The particular terms of each series of debt securities will
be described in a prospectus supplement relating to such series (including any pricing supplement or term sheet), including the following
terms, if applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the title and ranking of the debt securities
(including the terms of any subordination provisions);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the price or prices (expressed as a percentage
of the principal amount) at which we will sell the debt securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the aggregate principal amount of the debt securities
being offered and any limit on the aggregate principal amount of such series of debt securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">whether any of our direct or indirect subsidiaries
will guarantee the debt securities, including the terms of subordination, if any, of such guarantees;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the date or dates on which the principal of the
securities of the series is payable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the interest rate, if any, and the method for
calculating the interest rate;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the dates from which interest will accrue, the
interest payment dates and the record dates for the interest payments;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the place or places where principal of, and any
interest on, the debt securities will be payable (and the method of such payment), where the securities of such series may be surrendered
for registration of transfer or exchange, and where notices and demands to us in respect of the debt securities may be delivered;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any mandatory or optional redemption terms;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any obligation we have to redeem or purchase
the debt securities pursuant to any sinking fund or analogous provisions or at the option of a holder of debt securities and the period
or periods within which, the price or prices at which and the terms and conditions upon which securities of the series shall be redeemed
or purchased, in whole or in part, pursuant to such obligation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any dates, if any, on which and the price or
prices at which we will repurchase debt securities at the option of the holders of debt securities and other detailed terms and provisions
of such repurchase obligations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the denominations in which the debt securities
will be issued;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">whether the debt securities will be issued in
the form of certificated debt securities or global debt securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the currency of denomination of the debt securities,
which may be U.S. dollars or any foreign currency, and if such currency of denomination is a composite currency, the agency or organization,
if any, responsible for overseeing such composite currency;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the designation of the currency, currencies or
currency units in which payment of the principal of, and any interest on, the debt securities will be made;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">if payments of principal of, any interest on,
the debt securities will be made in one or more currencies or currency units other than that or those in which the debt securities are
denominated, the manner in which the exchange rate with respect to such payments will be determined;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the manner in which the amounts of payment of
principal of, or any interest on, the debt securities will be determined, if these amounts may be determined by reference to an index
based on a currency or currencies or by reference to a commodity, commodity index, stock exchange index or financial index;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any provisions relating to any security provided
for the debt securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any addition to, deletion of or change in the
events of default described in this prospectus or in the indenture with respect to the debt securities and any change in the acceleration
provisions described in this prospectus or in the indenture with respect to the debt securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any addition to, deletion of or change in the
covenants described in this prospectus or in the indenture with respect to the debt securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any depositaries, interest rate calculation agents,
exchange rate calculation agents or other agents appointed with respect to the debt securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the provisions, if any, relating to conversion
or exchange of any series of debt securities, including if applicable, the conversion or exchange price and period, the securities or
other property into which the debt securities will be convertible, provisions as to whether conversion or exchange will be mandatory,
at the option of the holders thereof or at our option, the events requiring an adjustment of the conversion price or exchange price and
provisions affecting conversion or exchange if such series of debt securities are redeemed; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any other terms of the series of debt securities
that may supplement, modify or delete any provision of the indenture as it applies to that series, including any terms that may be required
under applicable law or regulations or advisable in connection with the marketing of the debt securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue debt securities
that provide for an amount less than their stated principal amount to be due and payable upon maturity or a declaration of acceleration
of their maturity following an event of default pursuant to the terms of the indenture. We will provide you with information on the federal
income tax considerations and other special considerations applicable to any of these debt securities in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we denominate the purchase
price of any of the debt securities in a foreign currency or currencies or a foreign currency unit or units, or if the principal of and
any premium and interest on any series of debt securities is payable in a foreign currency or currencies or a foreign currency unit or
units, we will provide you with information on the restrictions, elections, general tax considerations, specific terms and other information
with respect to that issue of debt securities and such foreign currency or currencies or foreign currency unit or units in the applicable
prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Transfer and Exchange</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each debt security will be
represented by either one or more global securities registered in the name of The Depository Trust Company, or the depositary, or a nominee
of the depositary (we will refer to any such debt security as a &ldquo;global debt security&rdquo;), or a certificate issued in definitive
registered form (we will refer to any debt security represented by a certificate as a &ldquo;certificated debt security&rdquo;) as set
forth in the applicable prospectus supplement. Except as set forth below, global debt securities will not be issuable in certificated
form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Certificated Debt Securities</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may transfer or exchange
certificated debt securities at any office we maintain for this purpose in accordance with the terms of the indenture. No service charge
will be made for any transfer or exchange of certificated debt securities, but we may require payment of a sum sufficient to cover any
tax or other governmental charge payable in connection with a transfer or exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may effect the transfer
of certificated debt securities and the right to receive the principal of, premium and interest on certificated debt securities only by
surrendering the certificate representing those certificated debt securities and either reissuance by us or the trustee of the certificate
to the new holder or the issuance by us or the trustee of a new certificate to the new holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Global Debt Securities and Book-Entry System</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each global debt security
will be deposited with, or on behalf of, the depositary, and registered in the name of the depositary or a nominee of the depositary.
Beneficial interests in global debt securities will not be issuable in certificated form unless (i)&nbsp;the depositary has notified us
that it is unwilling or unable to continue as depositary for such global debt security or has ceased to be qualified to act as such as
required by the indenture and we fail to appoint a successor depositary within 90 days of such event, (ii)&nbsp;we determine, in our sole
discretion, not to have such securities represented by one or more global securities or (iii)&nbsp;any other circumstances shall exist,
in addition to or in lieu of those described above, as may be described in the applicable prospectus supplement. Unless and until a global
debt security is exchanged for certificated debt securities under the limited circumstances described in the previous sentence, a global
debt security may not be transferred except as a whole by the depositary to its nominee or by the nominee to the depositary, or by the
depositary or its nominee to a successor depositary or to a nominee of the successor depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Covenants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will set forth in the applicable
prospectus supplement any restrictive covenants applicable to any issue of debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>No Protection In the Event of a Change of Control</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless we state otherwise
in the applicable prospectus supplement, the debt securities will not contain any provisions which may afford holders of the debt securities
protection in the event we have a change in control or in the event of a highly leveraged transaction (whether or not such transaction
results in a change in control) which could adversely affect holders of debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Consolidation, Merger and Sale of Assets</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Centrus may not consolidate
with or merge with or into, or convey, transfer or lease all or substantially all of its assets to any person (a &ldquo;successor person&rdquo;)
unless:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Centrus is the surviving corporation or the successor
person (if other than Centrus) is a corporation organized and validly existing under the laws of any U.S. domestic jurisdiction and expressly
assumes Centrus&rsquo;s obligations on the debt securities and under the indenture; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">immediately after giving effect to the transaction,
no default or event of default, shall have occurred and be continuing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the above,
any of Centrus&rsquo;s subsidiaries may consolidate with, merge into or transfer all or part of its properties to Centrus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Events of Default</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I>Event of Default</I>&rdquo;
means with respect to any series of debt securities, any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">default in the payment of any interest upon any
debt security of that series when it becomes due and payable, and continuance of such default for a period of 30 days (unless the entire
amount of the payment is deposited by us with the trustee or with a paying agent prior to the expiration of the 30-day period);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">default in the payment of principal of any security
of that series at its maturity;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">default in the performance or breach of any covenant
by us in the indenture (other than defaults described above or defaults relating to a covenant that has been included in the indenture
solely for the benefit of a series of debt securities other than that series), which default continues uncured for a period of 60 days
after we receive written notice from the trustee, or we and the trustee receive written notice from the holders of not less than 25% in
principal amount of the outstanding debt securities of that series as provided in the indenture;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">certain voluntary or involuntary events of bankruptcy,
insolvency or reorganization of Centrus; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any other event of default provided with respect
to a series of debt securities, including any events of default relating to guarantors, if any, or subsidiaries that is described in the
applicable prospectus supplement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No event of default with respect
to a particular series of debt securities (except as to certain events of bankruptcy, insolvency or reorganization) necessarily constitutes
an event of default with respect to any other series of debt securities. The occurrence of certain events of default or an acceleration
under the indenture may constitute an event of default under certain indebtedness of ours or our subsidiaries outstanding from time to
time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an event of default with
respect to any series of debt securities at the time outstanding occurs and is continuing (other than an event of default resulting from
certain events of bankruptcy, insolvency or reorganization), then the trustee or the holders of not less than 25% in principal amount
of the outstanding debt securities of that series may, by a notice in writing to us (and to the trustee if given by the holders), declare
to be due and payable immediately the principal of (or, if the debt securities of that series are discount securities, that portion of
the principal amount as may be specified in the terms of that series) and accrued and unpaid interest, if any, on all debt securities
of that series. In the case of an event of default resulting from certain events of bankruptcy, insolvency or reorganization, the principal
amount (or such specified amount) of and accrued and unpaid interest, if any, on all outstanding debt securities will become and be immediately
due and payable without any declaration or other act on the part of the trustee or any holder of outstanding debt securities. At any time
after a declaration of acceleration with respect to debt securities of any series has been made, but before a judgment or decree for payment
of the money due has been obtained by the trustee, the holders of a majority in principal amount of the outstanding debt securities of
that series, by written notice to us and the trustee, may rescind and annul such declaration of acceleration and its consequences if all
events of default, other than the non-payment of accelerated principal and interest, if any, with respect to debt securities of that series,
have been cured or waived as provided in the indenture. We refer you to the prospectus supplement relating to any series of debt securities
that are discount securities for the particular provisions relating to acceleration of a portion of the principal amount of such discount
securities upon the occurrence of an event of default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The indenture provides that
the trustee will be under no obligation to perform any duty or exercise any of its rights or powers under the indenture unless the trustee
receives indemnity satisfactory to it against any cost, liability or expense which might be incurred by it in performing such duty or
exercising such right of power. Subject to certain rights of the trustee, the holders of a majority in principal amount of the outstanding
debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available
to the trustee or exercising any trust or power conferred on the trustee with respect to the debt securities of that series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No holder of any debt security
of any series will have any right to institute any proceeding, judicial or otherwise, with respect to the indenture or for the appointment
of a receiver or trustee, or for any remedy under the indenture, unless:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">that holder has previously given to the trustee
written notice of a continuing event of default with respect to debt securities of that series;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the holders of not less than 25% in principal
amount of the outstanding debt securities of that series have made written request to the trustee to institute the proceedings in respect
of such event of default in its own name as trustee under the indenture;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">such holder or holders have offered to the trustee
indemnity or security satisfactory to the trustee against the costs, expenses and liabilities which might be incurred by the trustee in
compliance with such request;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the trustee has failed to institute any such
proceeding for 60 days after its receipt of such notice, request and offer of indemnity; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">no direction inconsistent with such written request
has been given to the trustee during such 60-day period by holders of a majority in principal amount of the outstanding debt securities
of that series.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding any other
provision in the indenture, the holder of any debt security will have an absolute and unconditional right to receive payment of the principal
of, and any interest on, that debt security on or after the due dates expressed in that debt security (or, in the case of redemption,
on the redemption date) and to institute suit for the enforcement of any such payment and such rights shall not be impaired without the
consent of such holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The indenture requires us,
within 120 days after the end of our fiscal year, to furnish to the trustee a statement as to compliance with the indenture from our principal
executive officer, principal financial officer or principal accounting officer. If a default or event of default occurs and is continuing
with respect to the debt securities of any series and if it is actually known to a responsible officer of the trustee, the trustee shall
mail to each holder of the debt securities of that series notice of a default or event of default within 60 days after it occurs or, if
later, after a responsible officer of the trustee has knowledge of such default or event of default. The indenture provides that the trustee
may withhold notice to the holders of debt securities of any series of any default or event of default (except in payment on any debt
securities of that series) with respect to debt securities of that series if the trustee determines in good faith that withholding notice
is in the interest of the holders of those debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Modification and Waiver</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We and the trustee may modify
and amend or supplement the indenture or the debt securities of one or more series without the consent of any holder of any debt security:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">to add guarantees with respect to debt securities
of a series or secure debt securities of a series;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">to surrender any of our rights or powers under
the indenture;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">to add covenants or events of default for the
benefit of the holders of any series of debt securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">to comply with the applicable procedures of the
applicable depositary;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">to cure any ambiguity, defect or inconsistency;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">to comply with covenants in the indenture described
above under the heading &ldquo;Consolidation, Merger and Sale of Assets&rdquo;;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">to provide for uncertificated securities in addition
to or in place of certificated securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">to make any change that does not materially adversely
affect the rights of any holder of debt securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">to provide for the issuance of and establish
the form and terms and conditions of debt securities of any series as permitted by the indenture;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">to effect the appointment of a successor trustee
with respect to the debt securities of any series and to add to or change any of the provisions of the indenture to provide for or facilitate
administration by more than one trustee;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">to comply with requirements of the SEC in order
to effect or maintain the qualification of the indenture under the Trust Indenture Act; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">for certain other reasons set forth in any prospectus
supplement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may also modify and amend
the indenture with the consent of the holders of at least a majority in principal amount of the outstanding debt securities of each series
affected by the modifications or amendments. We may not make any modification or amendment without the consent of the holders of each
affected debt security then-outstanding if that amendment will:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">reduce the principal amount of debt securities
whose holders must consent to an amendment, supplement or waiver;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">reduce the rate of or extend the time for payment
of interest (including default interest) on any debt security;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">reduce the principal of, or change the fixed
maturity of, any debt security or reduce the amount of, or postpone the date fixed for, the payment of any sinking fund or analogous obligation
with respect to any series of debt securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">reduce the principal amount of discount securities
payable upon acceleration of maturity;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">waive a default in the payment of the principal
of, or interest, if any, on any debt security (except a rescission of acceleration of the debt securities of any series by the holders
of at least a majority in principal amount of the then-outstanding debt securities of that series and a waiver of the payment default
that resulted from such acceleration);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">make the principal of, or any interest on, any
debt security payable in currency other than that stated in the debt security;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">make any change to certain provisions of the
indenture relating to, among other things, the right of holders of debt securities to receive payment of the principal of, and any interest
on, those debt securities and to institute suit for the enforcement of any such payment;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">make any change to certain provisions of the
indenture relating to waivers or amendments; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">waive a redemption payment with respect to any
debt security, provided that such redemption is made at our option.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except for certain specified
provisions, the holders of at least a majority in principal amount of the outstanding debt securities of any series may, on behalf of
the holders of all debt securities of that series, by written notice to the trustee, waive our compliance with provisions of the indenture
or the debt securities with respect to such series. The holders of a majority in principal amount of the outstanding debt securities of
any series may, on behalf of the holders of all the debt securities of such series, waive any past default under the indenture with respect
to that series and its consequences, except a default in the payment of the principal of, or any interest on, any debt security of that
series; provided, however, that the holders of a majority in principal amount of the outstanding debt securities of any series may rescind
an acceleration and its consequences, including any related payment default that resulted from the acceleration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Defeasance of Debt Securities and Certain Covenants in Certain Circumstances</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Legal Defeasance</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The indenture provides that,
unless otherwise provided by the terms of the applicable series of debt securities, we may be discharged from any and all obligations
in respect of the debt securities of any series (subject to certain exceptions). We will be so discharged upon the deposit with the trustee,
in trust, of money and/or U.S. government obligations or, in the case of debt securities denominated in a single currency other than U.S.
dollars, government obligations of the government that issued or caused to be issued such currency, that, through the payment of interest
and principal in accordance with their terms, will provide money in an amount sufficient in the opinion of a nationally recognized firm
of independent public accountants or investment bank to pay and discharge each installment of principal and interest, if any, on and any
mandatory sinking fund payments in respect of the debt securities of that series on the stated maturity of those payments in accordance
with the terms of the indenture and those debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This discharge may occur only
if, among other things, we have delivered to the trustee an opinion of counsel stating that we have received from, or there has been published
by, the United States Internal Revenue Service a ruling or, since the date of execution of the indenture, there has been a change in the
applicable United States federal income tax law, in either case to the effect that, and based thereon such opinion shall confirm that,
the holders of the debt securities of that series will not recognize income, gain or loss for United States federal income tax purposes
as a result of the deposit, defeasance and discharge and will be subject to United States federal income tax on the same amounts and in
the same manner and at the same times as would have been the case if the deposit, defeasance and discharge had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Defeasance of Certain Covenants</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The indenture provides that,
unless otherwise provided by the terms of the applicable series of debt securities, upon compliance with certain conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">we may omit to comply with the covenant described
under the heading &ldquo;Consolidation, Merger and Sale of Assets&rdquo; and certain other covenants set forth in the indenture, as well
as any additional covenants which may be set forth in the applicable prospectus supplement; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any omission to comply with those covenants will
not constitute a default or an event of default with respect to the debt securities of that series (&ldquo;covenant defeasance&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The conditions include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">depositing with the trustee money and/or U.S.
government obligations or, in the case of debt securities denominated in a single currency other than U.S. dollars, government obligations
of the government that issued or caused to be issued such currency, that, through the payment of interest and principal in</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">accordance with their terms, will provide money
in an amount sufficient in the opinion of a nationally recognized firm of independent public accountants or investment bank to pay and
discharge each installment of principal of, and interest, if any, on and any mandatory sinking fund payments in respect of the debt securities
of that series on the stated maturity of those payments in accordance with the terms of the indenture and those debt securities; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">delivering to the trustee an opinion of counsel
to the effect that the holders of the debt securities of that series will not recognize income, gain or loss for United States federal
income tax purposes as a result of the deposit and related covenant defeasance and will be subject to United States federal income tax
on the same amounts and in the same manner and at the same times as would have been the case if the deposit and related covenant defeasance
had not occurred.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Governing Law</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The indenture and the debt
securities, including any claim or controversy arising out of or relating to the indenture or the securities, will be governed by the
laws of the State of New York (without regard to the conflicts of laws provisions thereof other than Section&nbsp;5-1401 of the General
Obligations Law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_010"></A>Description
Of Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following description,
together with the additional information we include in any applicable prospectus supplement, summarizes the material terms and provisions
of the warrants that we may offer under this prospectus, which consist of warrants to purchase shares of common stock, preferred stock
and/or debt securities in one or more series. Warrants may be offered independently or together with shares of common stock, preferred
stock and/or debt securities offered by any prospectus supplement and may be attached to or separate from those securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While the terms we have summarized
below will generally apply to any future warrants we may offer under this prospectus, we will describe the particular terms of any warrants
that we may offer in more detail in the applicable prospectus supplement. The specific terms of any warrants may differ from the description
provided below as a result of negotiations with third parties in connection with the issuance of those warrants, as well as for other
reasons. Because the terms of any warrants we offer under a prospectus supplement may differ from the terms we describe below, you should
rely solely on information in the applicable prospectus supplement if that summary is different from the summary in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will issue the warrants
under a warrant agreement, which we will enter into with a warrant agent to be selected by us. We use the term &ldquo;warrant agreement&rdquo;
to refer to any of these warrant agreements. We use the term &ldquo;warrant agent&rdquo; to refer to the warrant agent under any of these
warrant agreements. The warrant agent will act solely as an agent of ours in connection with the warrants and will not act as an agent
for the holders or beneficial owners of the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will incorporate by reference
into the registration statement of which this prospectus is a part the form of warrant agreement, including a form of warrant certificate,
that describes the terms of the series of warrants we are offering before the issuance of the related series of warrants. The following
summaries of material provisions of the warrants and the warrant agreements are subject to, and qualified in their entirety by reference
to, all the provisions of the warrant agreement applicable to a particular series of warrants. We urge you to read any applicable prospectus
supplement related to the warrants that we sell under this prospectus, as well as the complete warrant agreement that contain the terms
of the warrants and defines your rights as a warrant holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will describe in the applicable
prospectus supplement the terms relating to a series of warrants. If warrants for the purchase of debt securities are offered, the prospectus
supplement will describe the following terms, to the extent applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the offering price and the aggregate number of
warrants offered;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the currencies in which the warrants are being
offered;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the designation, aggregate principal amount,
currencies, denominations and terms of the series of debt securities that can be purchased if a holder exercises a warrant;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the designation and terms of any series of debt
securities with which the warrants are being offered and the number of warrants offered with each such debt security;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the date on and after which the holder of the
warrants can transfer them separately from the related series of debt securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the terms of any rights to redeem or call the
warrants;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the date on which the right to exercise the warrants
begins and the date on which that right expires;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">federal income tax consequences of holding or
exercising the warrants; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any other specific terms, preferences, rights
or limitations of, or restrictions on, the warrants.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Warrants for the purchase
of debt securities will be in registered form only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If warrants for the purchase
of shares of common stock or preferred stock are offered, the prospectus supplement will describe the following terms, to the extent applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the offering price and the aggregate number of
warrants offered;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the total number of shares that can be purchased
if a holder of the warrants exercises them;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the number of warrants being offered with each
share of common stock;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the date on and after which the holder of the
warrants can transfer them separately from the related shares of common stock or preferred stock;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the number of shares of common stock or preferred
stock that can be purchased if a holder exercises the warrant and the price at which those shares may be purchased upon exercise, including,
if applicable, any provisions for changes to or adjustments in the exercise price and in the securities or other property receivable upon
exercise;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the terms of any rights to redeem or call, or
accelerate the expiration of, the warrants;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the date on which the right to exercise the warrants
begins and the date on which that right expires;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">federal income tax consequences of holding or
exercising the warrants; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any other specific terms, preferences, rights
or limitations of, or restrictions on, the warrants.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Warrants for the purchase
of shares of common stock or preferred stock will be in registered form only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A holder of warrant certificates
may exchange them for new certificates of different denominations, present them for registration of transfer and exercise them at the
corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement. Until any warrants
to purchase debt securities are exercised, the holder of the warrants will not have any of the rights of holders of the debt securities
that can be purchased upon exercise, including any rights to receive payments of principal, premium or interest on the underlying debt
securities or to enforce covenants in the applicable indenture. Until any warrants to purchase shares of common stock or preferred stock
are exercised, holders of the warrants will not have any rights of holders of the underlying shares of common stock or preferred stock,
including any rights to receive dividends or to exercise any voting rights, except to the extent set forth under &ldquo;Warrant Adjustments&rdquo;
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exercise of Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each holder of a warrant is
entitled to purchase the principal amount of debt securities or number of shares of common stock or preferred stock, as the case may be,
at the exercise price described in the applicable prospectus supplement. After the close of business on the day when the right to exercise
terminates (or a later date if we extend the time for exercise), unexercised warrants will become void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A holder of warrants may exercise
them by following the general procedure outlined below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">deliver to the warrant agent the payment required
by the applicable prospectus supplement to purchase the underlying security;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">properly complete and sign the reverse side of
the warrant certificate representing the warrants; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">deliver the warrant certificate representing
the warrants to the warrant agent within five business days of the warrant agent receiving payment of the exercise price.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you comply with the procedures
described above, your warrants will be considered to have been exercised when the warrant agent receives payment of the exercise price,
subject to the transfer books for the securities issuable upon exercise of the warrant not being closed on such date. After you have completed
those procedures and subject to the foregoing, we will, as soon as practicable, issue and deliver to you the debt securities or shares
of common stock or preferred stock that you purchased upon exercise. If you exercise fewer than all of the warrants represented by a warrant
certificate, a new warrant certificate will be issued to you for the unexercised amount of warrants. Holders of warrants will be required
to pay any tax or governmental charge that may be imposed in connection with transferring the underlying securities in connection with
the exercise of the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Amendments and Supplements to the Warrant Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may amend or supplement
a warrant agreement without the consent of the holders of the applicable warrants to cure ambiguities in the warrant agreement, to cure
or correct a defective provision in the warrant agreement, or to provide for other matters under the warrant agreement that we and the
warrant agent deem necessary or desirable, so long as, in each case, such amendments or supplements do not materially adversely affect
the interests of the holders of the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Warrant Adjustments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the applicable prospectus
supplement states otherwise, the exercise price of, and the number of securities covered by, a warrant for shares of common stock or preferred
stock will be adjusted proportionately if we subdivide or combine our common stock or preferred stock, as applicable. In addition, unless
the prospectus supplement states otherwise, if we, without payment:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">issue shares of common stock or preferred stock
or other securities convertible into or exchangeable for common stock or preferred stock, or any rights to subscribe for, purchase or
otherwise acquire any of the foregoing, as a dividend or distribution to all or substantially all holders of our common stock or preferred
stock;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">pay any cash to all or substantially all holders
of our common stock or preferred stock, other than a cash dividend paid out of our current or retained earnings;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">issue any evidence of our indebtedness or rights
to subscribe for or purchase our indebtedness to all or substantially all holders of our common stock or preferred stock; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">issue common stock, preferred stock or additional
shares or other securities or property to all or substantially all holders of our common stock or preferred stock by way of spinoff, split-up,
reclassification, combination of shares or similar corporate rearrangement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">then the holders of common stock warrants or preferred
stock warrants will be entitled to receive upon exercise of the warrants, in addition to the securities otherwise receivable upon exercise
of the warrants and without paying any additional consideration, the amount of shares and other securities and property such holders would
have been entitled to receive had they held the common stock or preferred stock issuable under the warrants on the dates on which holders
of those securities received or became entitled to receive such additional shares and other securities and property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as stated above, the
exercise price and number of securities covered by a warrant for shares of common stock or preferred stock, and the amounts of other securities
or property to be received, if any, upon exercise of those warrants, will not be adjusted or provided for if we issue those securities
or any securities convertible into or exchangeable for those securities, or securities carrying the right to purchase those securities
or securities convertible into or exchangeable for those securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of common stock warrants
or preferred stock warrants may have additional rights under the following circumstances:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">certain reclassifications, capital reorganizations
or changes of the common stock or preferred stock;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">certain share exchanges, mergers, or similar
transactions involving us that result in changes of the common stock or preferred stock; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">certain sales or dispositions to another entity
of all or substantially all of our property and assets.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If one of the above transactions
occurs and holders of our common stock or preferred stock are entitled to receive shares, securities or other property with respect to
or in exchange for their securities, the holders of the common stock warrants or preferred stock warrants then-outstanding, as applicable,
will be entitled to receive upon exercise of their warrants the kind and amount of shares and other securities or property that they would
have received upon the applicable transaction if they had exercised their warrants immediately before the transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_011"></A>Description
Of Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following description,
together with the additional information we include in any applicable prospectus supplement, summarizes the general features of the rights
that we may offer under this prospectus. We may issue rights to our stockholders to purchase shares of our common stock and/or any of
the other securities offered hereby. Each series of rights will be issued under a separate rights agreement to be entered into between
us and a bank or trust company, as rights agent. When we issue rights, we will provide the specific terms of the rights and the applicable
rights agreement in a prospectus supplement. Because the terms of any rights we offer under a prospectus supplement may differ from the
terms we describe below, you should rely solely on information in the applicable prospectus supplement if that summary is different from
the summary in this prospectus. We will incorporate by reference into the registration statement of which this prospectus is a part the
form of rights agreement that describes the terms of the series of rights we are offering before the issuance of the related series of
rights. The applicable prospectus supplement relating to any rights will describe the terms of the offered rights, including, where applicable,
the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the date for determining the persons entitled
to participate in the rights distribution;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the exercise price for the rights;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the aggregate number or amount of underlying
securities purchasable upon exercise of the rights;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the number of rights issued to each stockholder
and the number of rights outstanding, if any;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the extent to which the rights are transferable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the date on which the right to exercise the rights
will commence and the date on which the right will expire;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the extent to which the rights include an over-subscription
privilege with respect to unsubscribed securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">anti-dilution provisions of the rights, if any;
and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any other terms of the rights, including terms,
procedures and limitations relating to the distribution, exchange and exercise of the rights.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders may exercise rights
as described in the applicable prospectus supplement. Upon receipt of payment and the rights certificate properly completed and duly executed
at the corporate trust office of the rights agent or any other office indicated in the prospectus supplement, we will, as soon as practicable,
forward the securities purchasable upon exercise of the rights. If less than all of the rights issued in any rights offering are exercised,
we may offer any unsubscribed securities directly to persons other than stockholders, to or through agents, underwriters or dealers or
through a combination of such methods, including pursuant to standby underwriting arrangements, as described in the applicable prospectus
supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_012"></A>Description
Of Units</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue units comprising
two or more securities described in this prospectus in any combination. For example, we might issue units consisting of a combination
of debt securities and warrants to purchase common stock. The following description sets forth certain general terms and provisions of
the units that we may offer pursuant to this prospectus. The particular terms of the units and the extent, if any, to which the general
terms and provisions may apply to the units so offered will be described in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each unit will be issued so
that the holder of the unit also is the holder of each security included in the unit. Thus, the unit will have the rights and obligations
of a holder of each included security. Units will be issued pursuant to the terms of a unit agreement, which may provide that the securities
included in the unit may not be held or transferred separately at any time or at any time before a specified date. A copy of the forms
of the unit agreement and the unit certificate relating to any particular issue of units will be filed with the SEC each time we issue
units, and you should read those documents for provisions that may be important to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The prospectus supplement
relating to any particular issuance of units will describe the terms of those units, including, to the extent applicable, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the designation and terms of the units and the
securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any provision for the issuance, payment, settlement,
transfer or exchange of the units or of the securities comprising the units; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">whether the units will be issued in fully registered
or global form.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_013"></A>Plan
Of Distribution</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may sell the securities
from time to time, by a variety of methods, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">on any national securities exchange or quotation
service on which our securities may be listed at the time of sale, including the NYSE American;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">in the over-the-counter market;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">in transactions otherwise than on such exchange
or in the over-the-counter market, which may include privately negotiated transactions and sales directly to one or more purchasers;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">through ordinary brokerage transactions and transactions
in which the broker-dealer solicits purchasers;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">through purchases by a broker-dealer as principal
and resale by the broker-dealer for its account;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">through underwriters, broker-dealers, agents,
in privately negotiated transactions, or any combination of these methods;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">through short sales;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">through the writing or settlement of options
or other hedging transactions, whether through an options exchange or otherwise;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">a combination of any of these methods; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">by any other method permitted pursuant to applicable
law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The securities may be distributed
from time to time in one or more transactions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">at a fixed price or prices, which may be changed;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">at market prices prevailing at the time of sale;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">at prices related to such prevailing market prices;
or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">at negotiated prices.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Offers to purchase the securities
being offered by this prospectus may be solicited directly. Agents may also be designated to solicit offers to purchase the securities
from time to time. Any agent involved in the offer or sale of our securities will be identified in a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a dealer is utilized in
the sale of the securities being offered by this prospectus, the securities will be sold to the dealer, as principal. The dealer may then
resell the securities to the public at varying prices to be determined by the dealer at the time of resale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an underwriter is utilized
in the sale of the securities being offered by this prospectus, an underwriting agreement will be executed with the underwriter at the
time of sale and the name of any underwriter will be provided in the prospectus supplement that the underwriter will use to make resales
of the securities to the public. In connection with the sale of the securities, we, or the purchasers of securities for whom the underwriter
may act as agent, may compensate the underwriter in the form of underwriting discounts or commissions. The underwriter may sell the securities
to or through dealers, and those dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters
and/or commissions from the purchasers for which they may act as agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise indicated
in a prospectus supplement, an agent will be acting on a best efforts basis and a dealer will purchase securities as a principal, and
may then resell the securities at varying prices to be determined by the dealer. Any compensation paid to underwriters, dealers or agents
in connection with the offering of the securities, and any discounts, concessions or commissions allowed by underwriters to participating
dealers will be provided in the applicable prospectus supplement. Underwriters, dealers and agents participating in the distribution of
the securities may be deemed to be underwriters within the meaning of the Securities Act, and any discounts and commissions received by
them and any profit realized by them on resale of the securities may be deemed to be underwriting discounts and commissions. In compliance
with the guidelines of the Financial Industry Regulatory Authority,&nbsp;Inc., or FINRA, the maximum amount of underwriting compensation,
including underwriting discounts and commissions, to be paid in connection with any offering of securities pursuant to this prospectus
may not exceed 8% of the aggregate principal amount of securities offered. We may enter into agreements to indemnify underwriters, dealers
and agents against civil liabilities, including liabilities under the Securities Act, or to contribute to payments they may be required
to make in respect thereof and to reimburse those persons for certain expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The securities may or may
not be listed on a national securities exchange. To facilitate the offering of securities, certain persons participating in the offering
may engage in transactions that stabilize, maintain or otherwise affect the price of the securities. This may include over-allotments
or short sales of the securities, which involve the sale by persons participating in the offering of more securities than were sold to
them. In these circumstances, these persons would cover such over-allotments or short positions by making purchases in the open market
or by exercising their over-allotment option, if any. In addition, these persons may stabilize or maintain the price of the securities
by bidding for or purchasing securities in the open market or by imposing penalty bids, whereby selling concessions allowed to dealers
participating in the offering may be reclaimed if securities sold by them are repurchased in connection with stabilization transactions.
The effect of these transactions may be to stabilize or maintain the market price of the securities at a level above that which might
otherwise prevail in the open market. These transactions may be discontinued at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If indicated in the applicable
prospectus supplement, underwriters or other persons acting as agents may be authorized to solicit offers by institutions or other suitable
purchasers to purchase the securities at the public offering price set forth in the prospectus supplement, pursuant to delayed delivery
contracts providing for payment and delivery on the date or dates stated in the prospectus supplement. These purchasers may include, among
others, commercial and savings banks, insurance companies, pension funds, investment companies and educational and charitable institutions.
Delayed delivery contracts will be subject to the condition that the purchase of the securities covered by the delayed delivery contracts
will not at the time of delivery be prohibited under the laws of any jurisdiction in the United States to which the purchaser is subject.
The underwriters and agents will not have any responsibility with respect to the validity or performance of these contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may engage in at-the-market
offerings into an existing trading market in accordance with rule&nbsp;415(a)(4)&nbsp;under the Securities Act. In addition, we may enter
into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated
transactions. If the applicable prospectus supplement so indicates, in connection with those derivatives, the third parties may sell securities
covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may
use securities pledged by us, or borrowed from us or others to settle those sales or to close out any related open borrowings of common
stock, and may use securities received from us in settlement of those derivatives to close out any related open borrowings of our common
stock. In addition, we may loan or pledge securities to a financial institution or other third party that in turn may sell the securities
using this prospectus and an applicable prospectus supplement. Such financial institution or other third party may transfer its economic
short position to investors in our securities or in connection with a concurrent offering of other securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The underwriters, dealers
and agents may engage in transactions with us, or perform services for us, in the ordinary course of business for which they receive compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_014"></A>Legal
Matters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise indicated
in the applicable prospectus supplement, certain legal matters in connection with the offering and the validity of the securities offered
by this prospectus, and any supplement thereto, will be passed upon by O&rsquo;Melveny&nbsp;&amp; Myers LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_015"></A>EXPERTS<SUP></SUP></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The financial statements of
Centrus Energy Corp. as of December&nbsp;31, 2024 and 2023, and for each of the two years in the period ended December&nbsp;31, 2024,
incorporated by reference in this prospectus by reference to Centrus Energy Corp.&rsquo;s <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000006/leu-20241231.htm">Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2024</A>, and the effectiveness of Centrus Energy Corp.&rsquo;s internal control over financial reporting have been
audited by Deloitte&nbsp;&amp; Touche LLP, an independent registered public accounting firm, as stated in their reports. Such financial
statements are incorporated by reference in reliance upon the reports of such firm given their authority as experts in accounting and
auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The financial statements for the year ended December 31, 2022 incorporated in this Prospectus by reference to the <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000006/leu-20241231.htm" STYLE="-sec-extract: exhibit">Annual Report on Form 10-K for the year ended December 31, 2024</A> have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent
registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to $1,000,000,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2530029d2_424b5img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Centrus Energy Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Class&nbsp;A Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 14pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-top: Black 1pt solid; padding-top: 2pt; text-align: center; padding-bottom: 2pt; border-bottom: Black 1pt solid"><B>Prospectus
Supplement</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Barclays</B></FONT></TD>
    <TD STYLE="text-align: center; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Citi</B></FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><B>UBS Investment Bank</B></TD>
    <TD STYLE="width: 25%; text-align: center"><B>Evercore ISI</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><B>B. Riley Securities</B> &nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Guggenheim
    Securities</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MUFG</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
    Blair</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lake
    Street</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Northland
    Capital Markets</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">November&nbsp;6, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>tm2530029d2_ex-filingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
  <head>
    <title>EX-FILING FEES</title>
  </head>
  <body>
    <div style="display: none">
      <ix:header>
        <ix:hidden>
          <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-330">S-3</ix:nonNumeric>
          <ix:nonNumeric name="ffd:SubmissnTp" contextRef="rc" id="ixv-331">424B5</ix:nonNumeric>
          <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="rc" id="ixv-332">EX-FILING FEES</ix:nonNumeric>
          <ix:nonNumeric name="ffd:RegnFileNb" contextRef="rc" id="ixv-333">333-291305</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="rc" id="ixv-334">0001065059</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-335">CENTRUS ENERGY CORP</ix:nonNumeric>
          <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"></ix:nonNumeric>
          <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ix:nonNumeric>
          <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="rc" id="hiddenrcCombinedProspectusTableNa">N/A</ix:nonNumeric>
          <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="rc" format="ixt:booleanfalse" id="ixv-339">The prospectus is not a final prospectus for the related offering.</ix:nonNumeric>
        </ix:hidden>
        <ix:references>
          <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
        </ix:references>
        <ix:resources>
          <xbrli:context id="rc">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001065059</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-11-06</xbrli:startDate>
              <xbrli:endDate>2025-11-06</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_1">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001065059</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-11-06</xbrli:startDate>
              <xbrli:endDate>2025-11-06</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:unit id="USD">
            <xbrli:measure>iso4217:USD</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="pure">
            <xbrli:measure>xbrli:pure</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="Shares">
            <xbrli:measure>xbrli:shares</xbrli:measure>
          </xbrli:unit>
        </ix:resources>
      </ix:header>
    </div>
    <div>
      <table style="width: 99%; font-family: Arial, Helvetica, sans-serif; font-size: 20pt; text-align: center;">
        <tr>
          <td colspan="4" style="padding-bottom: .5em">
            <p>
              <b>Calculation of Filing Fee Tables</b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-364">S-3</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-365">CENTRUS ENERGY CORP</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: left; word-wrap: break-word">
            <b>Table 1: Newly Registered and Carry Forward Securities</b>
          </th>
          <th style="vertical-align: bottom; word-wrap: break-word; text-align: right;">
            <span style="-sec-ix-hidden: hiddenrcOfferingTableNa">&#9744;Not Applicable</span>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; float: center; width: 100%; text-align: center; border: 1px solid black; font-size: 16px;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 12%;">
            <!-- BLANK -->
          </th>
          <th style="width: 2%;">
            <!-- BLANK -->
          </th>
          <th style="width: 12%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Type</b>
            </p>
          </th>
          <th style="width: 14%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Class Title </b>
            </p>
          </th>
          <th style="width: 2%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Calculation or Carry Forward Rule</b>
            </p>
          </th>
          <th style="width: 5%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount Registered</b>
            </p>
          </th>
          <th style="width: 15%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Proposed Maximum Offering Price Per Unit</b>
            </p>
          </th>
          <th style="width: 10%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Maximum Aggregate Offering Price</b>
            </p>
          </th>
          <th style="width: 5%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Rate</b>
            </p>
          </th>
          <th style="width: 6%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount of Registration Fee</b>
            </p>
          </th>
          <th style="width: 1%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward Form Type</b>
            </p>
          </th>
          <th style="width: 7%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward File Number</b>
            </p>
          </th>
          <th style="width: 6%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward Initial Effective Date</b>
            </p>
          </th>
          <th style="width: 7%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</b>
            </p>
          </th>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Newly Registered Securities</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_1" format="ixt:booleanfalse" id="ixv-366">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
		1
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_1" id="ixv-367">Equity</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_1" id="ixv-368">Class A Common Stock, par value $0.10 per share</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457rFlg" contextRef="offrl_1" format="ixt:booleantrue" id="ixv-369">457(r)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="Shares" decimals="0" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-370">1,000,000,000</ix:nonFraction>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-371">1,000,000,000.00</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-372">0.0001381</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-373">138,100.00</ix:nonFraction>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fees Previously Paid
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Carry Forward Securities</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Carry Forward Securities
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">Total Offering Amounts:</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; width: 16%;">
            <p id="MaxAggtOfferingPrice" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-374">1,000,000,000.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; border-bottom: 1px black; width: 16%;">
            <p id="TotalFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-375">138,100.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fees Previously Paid:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalPreviouslyPaidAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-376">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fee Offsets:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalOffsetAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-377">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Net Fee Due:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="NetFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:NetFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-378">138,100.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
      </table>
    </div>
    <div>
      <table style="width: 100%; text-indent: 0px;">
        <tbody>
          <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
            <td>
              <p style="margin:0pt;text-align:left; margin-bottom: 5px;">
                <b>Offering Note</b>
              </p>
            </td>
            <td/>
          </tr>
        </tbody>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="width: 100%; text-indent: 0px;">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">1</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_1" id="ixv-379">In accordance with Rule 457(r) under the Securities Act of 1933, as amended, the registrant initially deferred payment of all of the registration fee for a Registration Statement on Form S-3 (Registration Statement No. 333-291305), filed with the Securities and Exchange Commission on November 6, 2025.

The registrant is registering shares of Class A Common Stock having a proposed maximum aggregate offering price of $1,000,000,000 pursuant to this prospectus supplement.
</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: left; word-wrap: break-word">
            <b>Table 2: Fee Offset Claims and Sources</b>
          </th>
          <th style="vertical-align: bottom; word-wrap: break-word; text-align: right;">
            <span style="-sec-ix-hidden: hiddenrcOffsetTableNa">&#9745;Not Applicable</span>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 100%; text-align: center;  border: 1px solid black;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 10%; text-align: left;">
            <!-- BLANK -->
          </th>
          <th style="width: 8%; text-align: left;">
            <!-- BLANK -->
          </th>
          <th style="width: 16%;">
				Registrant or Filer Name
			</th>
          <th style="width: 6%;">
				Form or Filing Type
			</th>
          <th style="width: 7%;">
				File Number
			</th>
          <th style="width: 6%;">
				Initial Filing Date
			</th>
          <th style="width: 6%;">
				Filing Date
			</th>
          <th style="width: 6%;">
				Fee Offset Claimed
			</th>
          <th style="width: 6%;">
				Security Type Associated with Fee Offset Claimed
			</th>
          <th style="width: 8%;">
				Security Title Associated with Fee Offset Claimed
			</th>
          <th style="width: 6%;">
				Unsold Securities Associated with Fee Offset Claimed
			</th>
          <th style="width: 9%;">
				Unsold Aggregate Offering Amount Associated with Fee Offset Claimed
			</th>
          <th style="width: 6%;">
				Fee Paid with Fee Offset Source
			</th>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Rules 457(b) and 0-11(a)(2)</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Claims
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Sources
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Rule 457(p)</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Claims
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Sources
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: left; word-wrap: break-word">
            <b>Table 3: Combined Prospectuses</b>
          </th>
          <th style="vertical-align: bottom; word-wrap: break-word; text-align: right;">
            <span style="-sec-ix-hidden: hiddenrcCombinedProspectusTableNa">&#9745;Not Applicable</span>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 100%; border: 1px solid black;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 4%">
            <!-- Note column -->
          </th>
          <th style="width: 14%">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Type</b>
            </p>
          </th>
          <th style="width: 25%">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Class Title</b>
            </p>
          </th>
          <th style="width: 14%">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount of Securities Previously Registered</b>
            </p>
          </th>
          <th style="width: 18%">
            <p style="margin: 0pt; text-align: center;">
              <b>Maximum Aggregate Offering Price of Securities Previously Registered</b>
            </p>
          </th>
          <th style="width: 6%">
            <p style="margin: 0pt; text-align: center;">
              <b>Form Type</b>
            </p>
          </th>
          <th style="width: 10%">
            <p style="margin: 0pt; text-align: center;">
              <b>File Number</b>
            </p>
          </th>
          <th style="width: 8%">
            <p style="margin: 0pt; text-align: center;">
              <b>Initial Effective Date</b>
            </p>
          </th>
        </tr>
        <tr style="background-color:#E7E7E2;">
          <td style="text-align: center;">
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: center;">
		N/A
	</td>
          <td style="text-align: center;">
		N/A
	</td>
          <td style="text-align: center;">
		N/A
	</td>
        </tr>
      </table>
    </div>
  </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2530029d1_s3asrimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2530029d1_s3asrimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #5 7D# 2(  A$! Q$!_\0
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MP/X"55MK<_>PXZ9!P>?66J\$31@EG:3+.0S'+,'*'Y^."A4H@!($87OP)F)
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M>&8A-XAM]"UB;P_&R&16UF/3+MM+5XB"DJG4!;J4E*H<YR7"(W\>W[-'CO\
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M]/E9N>Q^LY>;W4KMII*]KNS:5^E['V$4Y-)*[=[*]KNS:5^FJ/BC]I3_ (*
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M\MRZ_P &/Q4\<^.?&7Q.\=^/OB#?ZI9_$R_\1Z]J?B*2YUC4-/UKPUXA@O\
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M\ :W=:%XD25)8W8#4]$M;6=[>41C[3IUW<_8[Q0L>I6VHV N--O/ZE_V /\
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M@9XR,FE+X7[ZIZ?&TI*/6]GH]K6??O8:3DTDTF]$WLO7[G^!*T@4 [6.1G
MS^/./UI5?=_"PXS\P ]NQ-5'N,*-NYB%9]L>)'.U68A50LS$D;5"@Y8JHR33
MX)4=PH9]S1"7;(IC;:2O/EN%D4KE0P9%VD[3\P(&5*LJSE&E"HU3^.K*$X1:
M6EX*48\U^Z5EZ6#5W2BI<OQ3A-245W:3=NEU?JBW1116P@HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH _E'_X**_MU_%SQM\6_%?PD\!>*?%OPN\%_#C7
MO%G@S68?"FJ^)_#NH^,_$GAWQ=K_ (<O=4U75?#=[HNJS^'#I6DZ=:VFGOJT
M-CJ%W/?7$\=S9V"P7GH7_!*']KCXN2?'JP^!OC3QAXA\?^#?'>C:^VFP>*_$
M-]XCU;P?KGAS2F\10'1O$%S))J,?AI]%T;6[(:!.+ZT36+[24LKG1H1<K<_H
MM^V?_P $PO"O[3_B*T\>>$O%\7PM^(4%I)I^IZP?#4OB31?$5BFHZKJNGMJF
MB6VO^&RNK:?<:UJD$>K_ &RZ:XL]0N8[JTFE6VF@V/V&_P#@FKX<_9(\1ZE\
M0]>\:'XE?$>[TV[T71]5&CW/A[1/"&CZG):-J]CH>DR:WK0FFO\ [)"S:A<&
M&ZCB,]HFV"XF+_BN X8XS_UYI9KB\RK2R:ECG6G0<VH5,.X8F/LVN?WE^]I^
MZX*[@GTN_P &P_"_'B\0L/G-;-*SR7#Y@Z\\/S/V57#NGBX>RE'G2FE[:G[O
M*DW3B_-_IB(Y9XG=0F\2SJ"QV,WDR201[G"OC&3(C;&Y4?*#R/FSQ+^QQ^SA
MXV\>1_$GQ5\'/ >N>-EF^U7.L7ND1;-0N4EO)%O]5L88HK'5M0G;4;N>>YOK
M>0BZE68"1XU8_4B1E%*\-P"7Z,SEF9B5 V@'.1@]21C'-*@(8DC'&,X]QQ7[
M'5PF#Q%&-#$X:ABJ=*:J4EB:4*SA--VE%S3::N]59]+M'[=5P.#QE*C''83#
MXKV%15J2Q%&%90JKFM)*::VD]+&3#I/DP)#&L,1BC%O#);L;=H(5C,$9C"Q%
M-\237,T"!$CMFD%M$#$#*?!/C-^R7\!OV@]2T?5/C#\,/"GCB_T'Y=+O]42\
MCO8+5)9+J+2KN>QELY=5T<7[)J!TV\E%JMTHD$3,I9_I:FLP4 D,<G "JS')
MSC. 0HX^\Q"CC)&11B<+A<906&Q6&H5\.K)4:E*,J=HN+2Y&G&R<8Z6Z(=;!
M8/$TG0Q.%H8F@THJAB*<:M&*3BTH4YIQBDX1:LM+);:'&:)X+TKPUX=T_P ,
M^'M/TWP_H^C6$5AI.EZ%!_9NG64%ID6BVUM&K_9DC0L)HHV=+HLRW/G122QO
M^('[-'_!(KX@_!']ISPU\4=8^*?A+4/A]\.=;UW6_"2Z';:K%XZU_P#M+3;[
M3(H-?@ET2QTOP]/<'5+F_P!4GTC7M;MWE5[73+#3;>_NS7[VK<QNQ5"'QW1X
MG! 'S, DC. K80[E!W,  0<AC$$*\:-DG#9 4IRH*NK$.#SNX!^520>4#<&,
MR3+\?7RZO5I.G4RNM&M@E1FZ-*E.,907-2@N2<>2<URMQ2;B[^ZD^#'\/Y9F
M5?+J]>E.G/*ZL:V#CAJLL-1ISA"<(\]*G%PG!*;]U\JVU5K%&7;!$5D2..'#
MM. Q,;*R 2NS,8_) 'F;V56WG]XY0EQ7\F?_  7L_P""LFJ^#]0UO]AS]FKQ
M/=:/XGN]-GTW]H7XA^']0%MK&@66LZ;M3X,>%=0MY7DT/Q!J=AJ&BWOC[64C
MM9],TC6;+P[H6HV^K7WB/6?!7]!?_!07]J?3?V-?V0_C5^T'=16=UJ_@?PQ&
MO@K3+^?R;75OB'X@U6R\.?#[3KORY4GFTVY\6:EI,FKV]MYEU)HD6H^7!*RF
M%O\ , \5:WKOBK7?%?B3Q?J^I^(/%'B36M5U[QCKNLW$E[K7B75KK5[K4;[4
M=7O$$TSW\U^^O37LME]KFN5N+BV1-\UO!'_3GT>_#JGQ=G6*SK'T(3RCA^+Q
M5.GB4I8;%8BE=RA7A*/)7I0A*4U2;2<XTI-KV44_R7QFX[?#N4X7)LOG;,<7
M)4L3RPYYPP\TH1=-J473J2J>RM45VH\T4K3;5+3-,O\ 49M$T;0-/U&^U/6+
MG3=%\/Z'X>L)=0U'4M5O6B@TK1=!TF&*XU%M:NS-+:V\11M5\7W4D<CM?ZG:
MQ7.I_P!4W[ '_!M[K7CK2M#^)7[=&NZKX!T^ZAM]5LOV?O D\-KXMDL[L12V
M]O\ %'QW-%J!TFXN+8RO>>&_!$LFH6ER\,5]XGT6_P!-OM$NO;?^#>[_ ()I
MZ7H_A2Q_;\^+^CPW'CKQBU[_ ,,]Z'J=A%=6_A+P/)JM_;ZC\6()KB,)>>(O
MBC/!>6OAN0V^?"_PQT[3O[!U 3^.Y[[1/ZQ;. Q*2VTL9)V4A=K;9G5B&/&X
MEDSDC<J;$=IG5IY?;\8_&BOBLSQ'"O!^)G@LIRJFL)4J1M*M2Q-.:C4_L^O&
M5*>$A'V<J:G33G9SA!Q7-*7E>&/A71>74N(>+J3S#,L?56)H4JLY*C##S3E#
MVV&G"K";:G=J4DGH[62M\%?"K_@EK_P3]^#>GZ?9^"OV0_@*MSIT4D4.N>+/
M .@_$CQ<4>2*39+XY^(FG>)O&<D;O#'*\*:[#;+,B21VX9$9.V\>_P#!/?\
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MM?%9Z/3<T=HI2G*G"+7VJD4KM::N2_#]2_O&2,'C/IVZ]ZC:8+_!(W^Z ?\
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M?ZWT]TUQ!.D<4B- V3(Q&PR1ERGEM!*3(!(L3NK@Q[6,4B^<DT,?^:A^W?\
M\%&/VL_VN+GQ)\#?CM\1-(\4?#SX;?&[6O%OA7P_9>$? NCWVC:[X9;QMX2T
M.6XUGP]I<.MWD,7ACQ9J=K);ZEJC1232++-9R36]O/%_H??LR?%*+X_?LV_
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M5"I4H<E>5";C2HU*L'>-3FJ>]3@F[7DVUN[+TG_@@'^VE^W3^UM/\8]#^/\
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MSY](7$5J&$X?@E4K8>IB5.G&A-TYRG*+4?WL.;W;24EIMMW/T'_8;_X*@?M
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M,/VG/B#X<T&Q$RR/;Z%KWA+X9?$29DCW%D2;Q1XV\37+ A45[G";B3C\)?\
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MBY\0[?RN4%R1=E!:)ROI\T?ME?+^R-^U*IZC]G'XUGVQ)\._$1'Y \_IFO\
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MJZA5YE)5L>U*NWS1BW%RNX1M:FM$V?&7_!1!"/V"_P!M\DC'_#'O[2B]>_\
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MW\0=4\&WVF>&M$\5Z;-=0>*-.\(R>%-:N)WTZ:31M!U#Q')I^G*EQJ<L4O\
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M;'E\E_WB+/$\B!F>*,%@9EB$A5"Q'R;\+?VL_ ?BCP#J/Q*\<W6E_#/PM/\
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M\4,A>&TN'5(S^?7[)$GQ&\=_MA_M0_$+XHW?A!_$?@/P)\*OA/#:_#=[[4O
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MT=XWGT;1+J\EU2.1M*(C\P>2:;^QMXYT+X7_ +(?PPM/$'AO7V^%/[1&D_M
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MK-]I&GW-K#*EN"]Q::?)?7$;)(/)\W"R?<VH>:;=O*<(TC+&L@",T9/(D"N
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M/!XS\4:_;ZE!>MJ4OB+0K30["R\(3V$$&C[+.VU;5VN[F^OI;DPND<MS]'4
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# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm2530029d2_424b5img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2530029d2_424b5img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #@ 8H# 2(  A$! Q$!_\0
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MHH **** "BBB@ HI,CU%+0 4444 %4-2UK3](5&OKCR@YPIV,V3^ -7Z\/\
M$=S<7?B/4'N2Q=9WC /\*JQ  ]L?XUA7J^SC='/B*SI1NCVN&XBN(DEB;<CC
M<IP1D5+7G?PSN;AFOK4EFMD574'HK$G./KC]*]$[5=.?/%2-*53VD%(****T
M- HHR/6C(]: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4$O;RY$\L?,:(N%4^ISUKBG3JNK=;'%.G5=;F6QVHZ"BBBNT[@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHK*U[7K70+$7%P&=F;;'&G5S_ (>])M)78FU%79JT5Q6D?$*W
MU"_CM+FS-J96"QOYF]2QZ \#&?QKM1T%3"<9J\63"I&:O%A15#5-6L]&M#<W
MLPCCSM'!)8^@ ZU7T;Q%IVN[Q9S$O&,M&XVL!Z^X^E/F5[7U'S1ORWU->BBB
MJ*./\:^&+K7/(N;(J9X05,;'&]3Z'U_QJ+P5X4O-&NIKZ_*)*\9B2)3G )!)
M)Z=ATKM:IZG?IIFFW%[(I984+[1U/H*Q=*'/[1[F+HPY_:/<N45POA_QY-JF
ML1V-U:1QB<D1O&2=IP3@YZ].OZ5W(Z"KA.,U>)5.I&:O$",UQ%Q\-K&6_:6*
M[FBMF;)A502/8-V'X&NXK!\1^)[;PZD7FQ/---G9&AQP.I)[#D5-2,&KSV0J
ML8-7GLC9MK>*UMHH(5"1Q($11V & *EK)T#7K?Q!9&XMU9"C;'C?JIZ_B,'K
M6M5Q::NMBXM-76P4F1ZTM>+^)]3O[CQ'>K-/*OD3LD2!B B@\$#L2,'/O6=:
MJJ:NT95JRI*[1[1D45S_ (-O;J_\-VTUX6:7+*';JX!P"?Y?A705I&7,DS6,
MN9)A1115%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %<7\0='N]1L[:ZM(GF-L7#QH,L5;'('?&W]:
M[2DJ)P4XN+(J04XN+/$M$T.^U/4X(HK>545P9)"I 0 \\^OM7MHZ"@  ]*6H
MI4E33L9T:*I)I'&>/]%OM4M;6>RB>8VY??$O4AL<@=\8Z>]97@/0-2MM7?4+
MJWFMHEB* 2*59R2.,'G''\J](HI.A%U.<'0BZGM""ZO+:QMS/=3QP1#J\C!1
M1:7EM?0":UGCFB/1XV##]*Y7Q[HNH:M:6KV,;3>0[%X5/)SC##UQ@_G1X"T:
M_P!)M+I[Y##Y[*4A8\C&<D^F<_I3YY>TY;:=Q^TE[3DMIW.QJ&ZM8;RVEMIT
M#Q2J5=3W!J4$>HI:V-CFM'\%Z7HVH?;86GDE7(C\U@0F>., =N.<UT@(Z9KD
MO'D.K2Z9 --6=D\P^<L )<C'' Y(ZY_"KO@V+4H] C75!*)=S;!-G>$[9SSZ
M]>V*QBU&7)%6,(-1G[.,;?D=#7.>*/"T7B)(7%P8)X<A7V[@0>H(R/2NCKC?
M&OB>^T.6V@LDC!E!<R2+NZ'H/Z_A557%0?/L55<5!\^QL>&_#\7AVP:!)3-)
M(V^20C&3TP!V%;59?A_4I-7T.UOIHO+DE4[E'3()&1['&?QK4JH)**Y=BH)*
M*Y=@R!WK*O\ P]I.IW(GO+**64?Q'@GZXZ_C5+QEK%UHNA^?: "6241!R,[
M03G'X8_&LCP+XCU'5KNYM+]_/V1^8LNT CG&#@8__4:SE4CS^S:(E4ASJF]S
MM8HHX8ECB0)&HVJJC  ] *DHHK8V"BBB@ HHHH **** "BBB@ HHHH ****
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MD]3QP,#I_ASW8Z5E3O)<TE9D4[R7--684445J:A1110 4444 %%%% !1110
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MU&5*_,PHHHKA.L**** "BBB@ HHHH **** "BBB@#E?&'CFR\&O9+>6ES/\
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M2A*"::O<>"C.,G='B7C_ /Y'[6O^OC_V45O?!_2HK_Q=+=S*&6R@,B CH['
M/Y;OTK"\?_\ (_:U_P!?'_LHKM?@<!]LUP]Q' /UDK>LVL)IV7Z&5-7Q.O=G
MLHZ5P?Q<LHKGP'<7#*"]K-%(A[C+A#^C&N\[5QWQ1_Y)UJW_ &Q_]')7C4'^
M]C;NCU*VM.7H?.+9VG'!Q7UMITYN=,M+AOO2PHY_%0:^2J^K]#_Y &F_]>L7
M_H KTLRVC\SAP&\CRSXY_P"MT#Z7/_M*N&\ _P#(^Z+_ -?'_LIKN?CG_K=
M^ES_ .TJX;P#_P C[HO_ %\?^RFMJ'^Z?)_J95O]Y^:/IOM7,?$/_D0=8_ZX
M?^S"NG[5S'Q#_P"1!UC_ *X?^S"O$I_&O5'JS^%GS17T-\*]%ATOP7;7(0"X
MOQ]HE?')!/R#Z!<?B3ZU\\U]2>$ !X+T+'_0.M__ $6M>SF4FH)=V>7@$G)O
MR-AE5UVL 0>H-.HHKPSUSYR^*?\ R474_I%_Z*6MSX)_\C+J'_7G_P"SK6'\
M4_\ DHNI_2+_ -%+6Y\%/^1EU#_KS_\ 9UKWJG^Y_)?H>1#_ 'KYL]QKE/B3
M_P D^U?_ '$_]#6NKKE/B3_R3[5_]Q/_ $-:\:C_ !(^J_,]2I\#]#YL-?4>
M@Q>=X*TN+.-^GQ+GTS&!7RY7U3X8_P"13T;_ *\8/_1:UZF9?#$\W ;R/EJ>
MVFLKB2UN$*3P.8Y%/9@<$?F*[GP!\1!X5B?3[ZV>>PDD\P/%C?$Q !X/!' ]
M".>N<5Z=XO\ AWI?BA)+A MGJ1.1=(F=_ &''\0X'N/SSXCXB\'ZUX8D/]HV
MI\C.%N8OFB;\>Q]C@UK"M2Q4.2>_];$3I5*$N>)[]HE]X9U^^?6-*>TGO60)
M)*%Q,JCH"#\R_P!:Z(=*^1[>XFM+B.XMII(9XSE)(V*LI]B*]Q^&GC^7Q"6T
MG52IU&--\<P  G4=<CH&'MU'T-<.)P4J:YXNZ.NABHS?*U9GI%%%%>>=H5X7
MK=]>ZAJDDU^"LX 78?X!@< =O7\:]TK!UCPEI>M3">XC=)P,&2)MI(]^Q_*N
M>O2E45DSFQ%*52-HLY/X:7-Q]NO;4%C;>6)".RMG'ZC/Y5Z4.E9VDZ+8Z);F
M&RBV!CEF)RS'W-:-72@X04671@X046%1SS);PO-*P2.-2S,>@ Y)J2JU]:I?
M6,]I(2$GC:-BO7!&#6C-7MH8.F^.-*U34ELHEGC=R1&\J *Y]!SD?B!4'B7P
M8-?U".]CO/L[A!&X,>X$ D@CD8/)K/T7P!-I^LQ7=S>1R0P/O144@L1TSZ?K
M7?#H*PA&52-JJ.>$95(-545M/LTT_3[>SB)*01K&I/4@#%/NK:&\M9;:XC$D
M,R%)$;HRD8(-349KH6FQT6TL?,/C#PM<^$]<DLY SVKDO:S'^-/?_:'0_GT(
MIOA3Q9?>$]3^U6I\R"3 GMV.%E4?R(YP?Z<5]$^(?#VG^)=+>PU"+=&WS(Z\
M-&W9E/8_Y/%> >*_ FK^%9G>:-KFPS\EW$IVX_VQ_"?KQZ&O<P^)A7A[.KO^
M9Y-:A*E+GAL>[>&_&&C^)[<-872^<%R]M(=LJ?4=Q[C(KH.U?(2.R.LB,5=3
ME6!P0?4&N@M/'?BJR0)!KMWM'_/4B7]7!K&IEKO>#^\UACE;WT?3M<QXG\<Z
M-X7B87-PLUWCY+2$@R$]L_W1[G]:\&O?&WB?4$*7.N7A4\$1OY0/_?&*P2<D
MD]2<DT4\NUO4?W!/'=((](TKXO:K%XBENM319--G(!MHP,P#L4/<^N>OM7L:
MS6/B+0F-M.D]G>0L@D3D%6!!_'V[5X#X1^'^J^*94F*/::;G+73K]X?[ _B/
MOT'Z5[_HNBV.@:7#I^GP^5!&.AY+$]68]R:QQD:,9+V>YKA75DGS['RS=6LU
MC>3VEPNV>"1HI!Z,IP?U%>R?!_Q/!-I9\/7$@6YMV9[<$_ZR,G) ]P23]"/0
MU4^*G@6:>>3Q%I<)D)'^F0H,G@8$@'?@ 'Z9]:\BBE>&1)89&CD0AD=&(*GU
M!'2N_P!S%T=]?R9Q>]AJNVA]=CH*SM=UNR\/Z3-J-_*$AC' _B=NRJ.Y->!6
MWQ/\6VT B&I"4 8#2PHS#\<<_CFL#5]=U77IUFU2^ENG7[H? 5?HHP!^ KCA
MET^;WFK'5/&QY?=6IW>C_&/5+;4IGU2V2ZL99"P2/"R0*3P%/1@/?D^M>PZ)
MK=EX@TR+4=/=GMY,X+(5((.""#Z'(KYU\)>#[_Q9J2PP*T5HC#[1=$?*@[@>
MK>WOSQ7TCINGVVE:=;V-G&([>! B+Z ?S/O48Z%&#2AN7A)U9*\]CYP\?_\
M(_:U_P!?'_LHKMO@=_Q]:[_N6_\ .2N)\?\ _(_:U_U\?^RBNV^!W_'UKO\
MN6_\Y*[J_P#NGR7Z')2_WGYL]DKCOBC_ ,DZU;_MC_Z.2NQKC?BE_P DZU7_
M +8_^CDKQJ'\6/JCTZW\.7HSYSKZOT/_ ) &F_\ 7K%_Z *^4#TKZOT/_D :
M;_UZQ?\ H(KT\RVC\SAP&\CRSXY_ZW0/I<_^TJX;P#_R/NB_]?'_ +*:[GXY
M_P"MT#Z7/_M*N&\ _P#(^Z+_ -?'_LIK6A_NGR?ZF5;_ 'GYH^F^U<Q\0_\
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M\;UCD#%<],XZ4 6:*** "BBB@ HHHH **** "LW7=3&C:-<WY3>8@-J^K$@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
/!1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Nov. 06, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001065059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">CENTRUS ENERGY CORP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-291305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Nov. 06, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Class A Common Stock, par value $0.10 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 1,000,000,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 138,100.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">In accordance with Rule 457(r) under the Securities Act of 1933, as amended, the registrant initially deferred payment of all of the registration fee for a Registration Statement on Form S-3 (Registration Statement No. 333-291305), filed with the Securities and Exchange Commission on November 6, 2025.

The registrant is registering shares of Class A Common Stock having a proposed maximum aggregate offering price of $1,000,000,000 pursuant to this prospectus supplement.
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Nov. 06, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 1,000,000,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">138,100.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 138,100.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2530029d2_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="tm2530029d2_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="tm2530029d2_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="tm2530029d2_ex-filingfees.htm">tm2530029d2_ex-filingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2530029d2_ex-filingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "tm2530029d2_ex-filingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 10,
    "http://xbrl.sec.gov/dei/2025": 2,
    "http://xbrl.sec.gov/ffd/2025": 8
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 23,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2530029d2_ex-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2530029d2_ex-filingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2530029d2_ex-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2530029d2_ex-filingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001104659-25-107429-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-107429-xbrl.zip
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M'IB$7X1QWA#_CXKN_P%02P$"% ,4    " "V0&9;W8'AG2$,  #U8@  '0
M            @ $     =&TR-3,P,#(Y9#)?97@M9FEL:6YG9F5E<RYH=&U0
52P4&      $  0!+    7 P

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>tm2530029d2_ex-filingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001065059</identifier>
        </entity>
        <period>
            <startDate>2025-11-06</startDate>
            <endDate>2025-11-06</endDate>
        </period>
    </context>
    <context id="offrl_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001065059</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-06</startDate>
            <endDate>2025-11-06</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-330">S-3</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-331">424B5</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-332">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:RegnFileNb contextRef="rc" id="ixv-333">333-291305</ffd:RegnFileNb>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-334">0001065059</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-335">CENTRUS ENERGY CORP</dei:EntityRegistrantName>
    <ffd:OfferingTableNa contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="rc" id="hiddenrcCombinedProspectusTableNa">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FnlPrspctsFlg contextRef="rc" id="ixv-339">false</ffd:FnlPrspctsFlg>
    <ffd:FormTp contextRef="rc" id="ixv-364">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-365">CENTRUS ENERGY CORP</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="offrl_1" id="ixv-366">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_1" id="ixv-367">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_1" id="ixv-368">Class A Common Stock, par value $0.10 per share</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="offrl_1" id="ixv-369">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="offrl_1"
      decimals="0"
      id="ixv-370"
      unitRef="Shares">1000000000</ffd:AmtSctiesRegd>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-371"
      unitRef="USD">1000000000.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-372"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-373"
      unitRef="USD">138100.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="rc" decimals="INF" id="ixv-374" unitRef="USD">1000000000.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="rc" decimals="INF" id="ixv-375" unitRef="USD">138100.00</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="rc" decimals="INF" id="ixv-376" unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="rc" decimals="INF" id="ixv-377" unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="rc" decimals="INF" id="ixv-378" unitRef="USD">138100.00</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="offrl_1" id="ixv-379">In accordance with Rule 457(r) under the Securities Act of 1933, as amended, the registrant initially deferred payment of all of the registration fee for a Registration Statement on Form S-3 (Registration Statement No. 333-291305), filed with the Securities and Exchange Commission on November 6, 2025.

The registrant is registering shares of Class A Common Stock having a proposed maximum aggregate offering price of $1,000,000,000 pursuant to this prospectus supplement.
</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
